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Abstract
The research work performed during the doctorate course included computa-
tional simulations on different protein systems.
One of these threads concerned the influence of an oxydating or reducing
environment on the structural properties of human Neuroglobin and their re-
lations with the protein’s functional properties in presence and absence of a
disulfide bridge. The aim of this thread, followed in collaboration with prof.
Darío Estrin’s group (Universidad de Buenos Aires) and with dr. Zosia Gasik,
PhD student at the University of Warsaw, was to shed some light on the open
question about the physiological redox state of Neuroglobin and, ultimately, on
this protein’s role and functions.
The present thesis reports exclusively about the main research thread con-
cerning Rhodnius prolixus Nitrophorin 7, a peculiar member of a family of nitric
oxide trasporting proteins. This particular protein displays a distinctive be-
haviour, when compared with the other, better known members of its family, in
terms of NO transport and release mechanisms and of interactions with phos-
pholipidic membranes. The computational studies, aimed at clarifying aspects
such as the structure of the system of cavities and tunnels inside the protein,
the pH-triggered conformational transition, the membrane interaction and its
influence on the NO stocking and release, were conducted in collaboration with
prof. F. Javier Luque’s group (Universitat de Barcelona) and dr. Markus Knipp’s
group at the Max Planck Institut für chemische Energiekonversion (Mülheim a.
d. Ruhr).
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Chapter 1
Rhodnius prolixus Nitrophorins
Triatomine Rhodnius prolixus Stål. (Rp hereafter, see Figure 1.1), also known as
the “kissing bug”1, is an insect long known (see e.g. Buxton [1]) and associated
to American trypanosomiasis (Kirchhoff [2]), also known as Chagas disease,
caused by parasite protozoan Trypanosoma cruzi hosted by the insect itself. For
this reason especially, Rp and its blood-feeding process have been studied with
particular interest in recent times.
1.1 A family of four
The platelet antiaggregating effect of Rp’s saliva is known since the 80s[3, 4].
The first literature encounters with the specific protein(s) responsible for this
effect date back to the early 90s. In Ribeiro et al. [5] the identification of a
protein containing a nitrosylheme with a FeIII heme reversibly binding nitric
1This common name is sometimes used (esp. in non-scientific or divulgative literature) to
indicate Rp or other triatomines with similar blood-feeding habits; its origin probably lies in a
common belief about the insect’s dislike for clothed skin and its preference for biting humans on
bare, uncovered areas, especially during the night, and therefore frequently on the face.
Figure 1.1: Rhodnius prolixus in its hemimetabolism stages from nymph to
adult. Source: Wikipedia.
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oxide (NO), as responsible of the release of NO at neutral pH, is made, while in
Ribeiro and Walker [6] the peculiar property of releasing NO upon histamine
binding, particularly advantageous for a blood-sucking insect, is investigated,
to the conclusion that the protein responsible is a FeIII heme protein, with a
particularly high affinity for histamine binding (see also Walker [7]).
In Champagne et al. [8] for the first time there is a mention of Nitrophorins
(NP1-4), as four different proteins isolated from the insect’s salivary glands.
Sequence and experimental similarities are also reported between NP1 and
NP4, and between NP2 and NP3. An account of NP1 cloning is also given.
A previous course of research on the kissing bug had shown the presence
of two peptidic anticoagulant agents, namely Prolixin-S and Prolixin-G[9]. In
Ribeiro et al. [10] Prolixin-S is proved to be NP2. Sequencing and cloning
of Prolixin-S/NP2 is reported in Sun et al. [11]. An account of NP2’s anti-
hemostatic properties is given in Zhang et al. [12]. Kinetic measurements on
Prolixin-S, regarding load and release of NO, are reported in Kaneko et al.
[13] and suggest that while NO loading is a pH independent process, after the
protein undergoes a conformational change subsequent to Fe-NO binding, the
release is, on the contrary, made faster by a higher pH.
In Sun et al. [14] the red hemoprotein labelled as RpSG I is cDNA-cloned
and found to have the same N-terminal sequence as NP3, thus reconducting
the research line about RpSG proteins (RpSG II being Prolixin-S, see Yuda et al.
[15], i.e. NP2) to Nitrophorins.
An analysis on recombinant NP1 is provided by Andersen et al. [16], in
terms of NO binding and absorption spectra, which are indistinguishable from
the insect-derived protein, where the rates of NO binding and release and the
Soret absorption maxima are all pH-dependent. The first data about NP1 crys-
tals are also reported. A complete crystal structure analysis of NP1 is provided
by Weichsel et al. [17], where for the first time the heme is found to be "sand-
wiched between strands of a lipocaline-like β-barrel, and in an arrangement
unlike any other gas-transport protein discovered to date". A deeper analysis
about the FeIII-NO and FeII-NO forms of NP1 is reported in Ding et al. [18].
Andersen et al. [19] focus on NP4, and summarize some striking properties,
such as:
• whereas NO binds almost irreversibly in globins, binding to Rp Nitro-
phorins is readily reversible thanks to heme stabilization in FeIII form;
• whereas methemoglobin and metmyoglobin readily autoreduce to FeII
forms, where NO binding is extremely tight, Nitrophorins are resistant to
iron autoreduction and are thus well-suited as NO transporters;
• Nitrophorins bind NO more tightly at pH 5.0 (supposedly similar to the
insect’s salivary glands pH) than at pH 7.4 (the blood’s pH, where the
saliva is injected in the host’s body), optimizing the process of NO load-
and-delivery;
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• Nitrophorins are able to tightly bind histamine through heme coordina-
tion once NO has been released and this appears to be the source of a
strong antihistaminic activity in the insect’s saliva; in addition, NP1 has
been reported to have thiol oxydase activity, and NP2 an anticoagulant
activity (not related to the heme moiety, but rather to the inibition of the
conversion of factor X to Xa in the blood coagulation cascade);
• each of the four NPs seems to have two NO-off rates which differ among
the four proteins, and this suggests that the presence of four of them is
aimed at adding more functionalities and to fine-tune the release of NO
over a longer period of time;
• NP1-4 share a 38% sequence identity, while NP1 and NP4 have 90%
sequence identity and the next most similar couple is NP2 and NP3 with
a 79% sequence identity;
• one common feature in the crystal structures of NP1 and NP4 is the pres-
ence of a buried ionizable residue (Glu55) with water molecules around
it.
In Andersen et al. [20] kinetic and thermodynamic analyses for ligand bind-
ing by all four proteins are presented, together with reduction potentials. The
results are discussed in the light of the crystal structures of NP1, NP2, NP4,
displaying open polar distal pockets, and of NP4-NO, displaying a NO-induced
conformational change that leads to expulsion of solvent molecules and com-
plete burial of NO in a nonpolar distal pocket (see Weichsel et al. [21]). The
conclusion that is drawn from these data is that the tight NO binding is due to a
conformational trap rather than to particularly strong bonds (hydrogen bonds
or Fe-NO).
More information about NP1-4 comes from Andersen and Montfort [22],
reporting an analysis of the crystal structure of NP2 and a comparison with the
other three Nitrophorins. As NP2 (and partly NP3) has a peculiar anticoagulant
action, a surface region near the C-terminus and the BC- and EF-loops are held
responsible for this particular feature. Another specific trait of NP2 is having
higher NO association and lower NO dissociation rates than NP1,4: for this, the
difference in the protein core is considered crucial: Glu53’s protonation state
is taken as the release switch and in the case of NP2, a deprotonated Glu552
would hydrogen bond with Tyr81, which lies within the core and not on the
protein surface as in NP1 and NP4.
Montfort et al. [23] review several antihemostatic proteins characterized by
a Lipocalin fold and found in different insects such as Rp. The paper proposes a
division of eight Rp saliva proteins into four groups, of which the first includes
2Position 55 in NP1,4 corresponds to position 53 in NP2,3 and to position 56 in NP7. As can
be seen in Figure 1.4, this is the position of a conserved Glu residue.
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the four Nitrophorins3. Three functions are described for NP1-4:
1. NO-storage and transport; released in the target tissue, NO binds to sol-
uble guanylate cyclase, resulting in a signal cascade that causes smooth
muscle relaxation and vasodilation.
2. Histamine binding; Histamine is released by the host’s mast cells as a
signal for inflammation and request for immune response and wound
healing.
3. Preventing blood coagulation, interfering with the cascade at the factor
X maturation step. This function is reported only for NP2/Prolixin-S (see
Isawa et al. [26]).
The main points this review underlines are:
• the Nitrophorin family arose through gene duplication; the NP1,4 and
NP2,3 pairwise sequence similarity is followed by a functional similarity,
especially with respect to the kinetics of NO binding and release;
• as Lipocalins they function binding a hydrophobic molecule at one end
of the typical barrel; in NP1-4 the hydrophobic molecule is the heme,
tightly packed at one end of the barrel and with ten hydrophobic contacts
in addition to proximal His; this results in a distorted ("ruffled") heme,
which "may contribute to the stability of the ferric oxydation state";
• NP1-4 share the same structure formed by an 8-stranded β-barrel, three
short helical segments and two disulphide bonds; when NO is absent,
the distal pocket is open and water-filled and loops AB and GH, at the
"mouth" of the barrel (i.e. at the wider end where the heme is bound)
are mobile;
• Lys88 and Lys125, which in NP1,4 are in the distal pocket and bind to
the heme propionates, in NP2 are not present and this makes the distal
cavity larger in the latter Nitrophorin.
In Roberts et al. [27] a refinement of the crystal structures of NP4-NO and
NP4-NH3 is offered. This allows to further appreciate the heme ruffling taking
place once the cofactor is liganded. Some interesting conclusions are drawn.
First of all, heme ruffling is considered instrumental to a higher stability of
the ferric FeIII status of the heme. Other elements that can help to achieve
this function are negatively charged carboxylate groups in the proximity of
the heme, or the presence of a hydrophobic cage around the NO ligand, or the
3The second group of proteins are the Rp aggregation inhibitors RpAI 1-3 (see also Franci-
schetti et al. [24, 25]), and are apparently lipocalins without heme. The third group includes
only one protein, an Apyrase which hydrolizes ADP to AMP. The fourth group includes only
Rhodniin, an antithrombin protein.
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impossibility to lengthen or dissociate the proximal histidine-heme bond, which
would be required if the reduction to ferrous takes place. Another important
question is raised about the role of Glu55 as a pH switch, as the presence of
water molecules does not seem to change in crystals prepared at different pHs.
The importance of the hydrophobic cage in terms of heme ruffling and FeIII-
NO stabilization has been studied in detail on NP2 and mutants by Shokhireva
et al. [28] through NMR and spectroelectrochemical assays.
Maes et al. [29] report Raman spectroscopy studies on NP1-NO and NP1-
CN, thereby determining bond strength and geometric parameters.
1.2 The family gets larger
Andersen et al. [30] report of the discovery of a possible novel member of
the Rp Nitrophorin family, characterized by the usual Lipocalin fold, amine-
binding, especially active binding serotonin and (nor)epinephrin.
Furthermore, Ribeiro et al. [31] account for a comprehensive search of the
sialome (i.e. the set of mRNA plus the set of proteins found in the salivary
glands) of Rp and other triatomines. While NPs seem to be peculiar to Rp,
although different NPs appear at different instar stages, the NP family acquires
three new members, labelled NP2A, NP3A and NP4A, according to a philo-
genetic analysis of their sequences. This work also criticizes the labelling of
NP5 and NP6 in Moreira et al. [32], as the sequences identified in the latter
work are not found in the former and differ only by single substitutions from
the sequences of NP4 and NP2 respectively. An interesting remark about poly-
basic sequences found in the new NPs near the C-terminal is made, as these
sequences seem to be experimentally related to protein adsorption to a nega-
tively charged membrane, such as platelet membranes due to the exposure of
PS upon platelet activation, as a procoagulant surface promoting the assembly
of coagulating factors.
NP7 (see Figure 1.2) first appears in Andersen et al. [33]. Recombinant NP7
is described as the only NP able to bind to anionic membranes. Upon sequence
alignment, NP2-3 are the closest sequences to NP7’s. The proposed function is
a nonspecific blocking of membrane coagulation factor binding site, and at the
same time delivering NO and binding histamine. Compared to NP1-4, more
abundant, not binding to membranes and therefore remaining free in solu-
tion, NP7’s action appears to be localized in the vicinity of the feeding wound,
acting as platelet aggregation inhibitor, antihistamine and anticoagulant. The
particular dependence of the membrane binding on salt concentration4 and the
lack of binding to PC vesicles (as opposed to PS ones) suggests that the NP7 -
anionic membrane interaction is simply mediated by electrostatic contacts be-
tween positively charged residues on the protein surface and the negatively
4No binding is reported on 100% PC membranes, complete binding on 100% PS membranes
in the absence of NaCl, and no detectable binding on 100% PS membranes at 640 mM NaCl.
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Figure 1.2: Rp NP7, cartoon backbone representation, iceblue CPK heme:CO.
In yellow: the β-barrel; in purple: the α-helices; in cyan: loops. (VMD)
charged PS heads. The membrane interaction domain is pointed out as the α-
helix sequentially following the Lipocalin β-barrel and before the C-terminus,
where five K residues are solvent-exposed.
Meanwhile, studies on the "old" members, especially NP4, advance.
Ascenzi et al. [34] provide an interesting educational remark as NP1-4 can
be used, together with other globins, namely Hemoglobins, as excellent molec-
ular models to illustrate the completely different folds of gas storage and trans-
port heme proteins, representing a unique evolutionary case.
Maes et al. [35], through stopped-flow spectroscopy on NP4 and AB- and
GH-loop mutants conclude that the pH dependency for NO release is related
to loop dynamics. An interesting remark is that the multi-phasic behaviour
of NP4 NO release is not affected by mutations, and this should be detected in
terms of static or dynamic active site heterogeneity (as pointed out by Nienhaus
et al. [36]), but this cannot be seen in ultra-high resolution X-ray structures
(see Kondrashov et al. [37]). A conformational change is reported for NP4 as
follows: in the absence of NO, the distal heme pocket is open, the AB loop
poorly ordered and the GH loop away from the "mouth" of the barrel. Upon
NO binding, the AB and GH loops collapse into the binding pocket, ejecting
solvent and packing nonpolar sidechains around the ligand. Asp30 becomes
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buried and hydrogen bonds with Leu130, while Glu32, Asp35 and Asp129 and
the N-terminus come together and form a network of hydrogen bonds. This,
together with the fact that the NO molecule is stored in a nonpolar pocket and
forms no hydrogen bonds with the protein suggests that the conformational
changes are mediated through hydrophobic interactions. The distal loop is
thus reported crucial for the NP4 pH sensitivity; in order to evaluate the role of
the distal pocket hydrophobicity towards NO affinity, a comparison with NP2
is proposed: NP2 binds NO more tightly, displays faster association and slower
dissociation than NP4, and one of the key structural differences highlighted is
that whereas in NP4 Thr121, lying in the back of the distal pocket, orders a
water molecule near the NO binding site, in NP2 the corresponding residue is
Ile120, with the concomitant loss of the ordered water molecule.
Nienhaus et al. [36] propose IR spectroscopy to study structural hetero-
geneity, especially using firstly CO as a probe molecule, due to its strong IR
absorbance bands in the heme-bound forms and when trapped in the protein
matrix, and then physiologically relevant NO. A specific technique here repli-
cated after studies on Myoglobins involves X-ray structures of NP4 at 100K
in presence of Xe, since hydrophobic cavities (Xe cavities) effectively trap Xe
atoms in these conditions. One interesting result is that hydrophobicity and
structural homogeneity of the NP4-CO distal pocket increase with decreasing
pH. In terms of Xe cavities, the low temperature results show that there are
no such pockets except for one in the proximal side, impossible to reach by
photolyzed ligands. The spectroscopic observations here lend strong support to
a ligand release mechanism that does not depend on the existence of internal
cavities but is mainly based on a large scale structural rearrangement between
a hydrophobic, closed, low pH structure and a hydrophilic, open, higher pH
conformation. Benabbas et al. [38] confirm these findings and shed some addi-
tional light on the NP4 storage and release of NO (and CO, used in conjunction
with FeII). Geminate recombination is attributed to rebinding from the distal
pocket; the kinetic response of FeIII− NO exhibits two exponential phases, the
slower one interpreted as recombination from the hydrophilic open conforma-
tion, the faster one from the hydrophobic closed one. The overall off-rate of NO
is seen to increase by more than one order of magnitude in the passage from
pH 5.0 to pH 8.0.
More studies on NP4 include binding properties with 4-iodopyrazole and
imidazole (Berry et al. [39]).
In 2005 Menyhárd and Keserü [40] report Molecular Dynamics studies (MD
hereon) about the protonation states of ionizable residues in NP4, assigning to
Asp30 and its protonation state a particularly relevant role for the conforma-
tional transition between the low and high pH conformers.
Maes et al. [41] analyse the properties of NP4 with non-physiological fer-
rous heme.
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In the same year, a review of properties of the seven known NPs5 is given
in Andersen et al. [42], while Walker [7] provides a detailed analysis of the
{FeNO}6 complex in insect NPs (including Cimex lectularius - bedbug - NP).
In Ambrus et al. [43] the fact that NP1-4 can exist in multiple oligomer-
ization states leads to the suggestion that their intensive, moderately pH- and
ligand-dependent oligomerization has physiological implications.
An issue that Berry et al. [44] investigates is common to NP1-3 and NP7,
and not to NP4 and involves the role of the N-terminus. As in E. coli NP4 is
the only family member expressed with the initial methionine cleaved off, in
account of the first residue being an alanine, the NP2(D1A) mutant is studied
and found to possess some different properties from recombinant NP2-M0D1.
This suggests that it is possible that the presence of M0 in all recombinant ex-
pressions of NP1-3 and NP7, which differentiates said recombinant proteins
from the mature native Rp ones, are affected by the same differences. These
differences are very slight in terms of reduction potentials FeIII/FeII or of the
dissociation constant K IIId ; they are much more significant, though, in what con-
cerns the ratio of the two heme isomers A and B (see Figure 1.3; Shokhireva
et al. [45] for the identification of the two isomers in NP2, Shokhireva et al.
[46, 47] in NP1 and NP4, Shokhireva et al. [48] in NP3), which have different
release kinetics in different NPs, and their equilibrium relaxation times. The
conclusion drawn in that paper is that "the differences in equilibrium A:B ra-
tio and rates of NO release for each of the isomers of each of the nitrophorins
provide kinetic data that are probably not representative of the nitrophorins
in the salivary glands of the insect, where the proteins are likely kinetically
trapped by NO binding, with non-equilibrium A:B hemin ratios. (...) mu-
tants such as NP1(K1A) and NP3(D1A) should be prepared and investigated
by the techniques used in this study. (...) Only then will it be possible to
make conclusions as to the physiological consequences of kinetic trapping of
non-equilibrium hemin ratio on the profiles for release of NO and binding of
histamine by the physiological mixture of the four nitrophorins".
A study on the crystal structure of apo-NP4, Amoia and Montfort [49],
shows that the β-barrel is not affected by the presence or absence of the cofac-
tor, and therefore it appears to be rigid and strong enough to force distortions
upon the heme cofactor itself.
Kondrashov and Montfort [50] report a comparative MD study of NP4 and
Myoglobin with a free NO ligand (using a NO model after Meuwly et al. [51]).
NP4 is here simulated at two different pH (5 and 7) through the different proto-
nation states of ionizable residues: while Asp70 and Glu55 are kept protonated
at both pH 5 and pH 7, Asp30 and Asp35 are considered charged at pH 7 and
neutral at pH 5, and His120 and His124 are neutral at pH 7 and protonated at
5Actually, only five, i.e. NP1-4 and NP7, are explicitly presented in [42], probably due to
a poor identification of NP5 and NP6, as seen above; this is reflected still nowadays, as in
databases only those five structures or even sequences are found under the Rp NP names.
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Figure 1.3: Heme in A and B orientations. Source: [55]
pH 5. This study allows to separate two different conformations for NP4 and
shows NO trapping within the protein matrix, in agreement with previous ki-
netic data. Applying Multiple Steering MD (MSMD hereon) and Quantum Me-
chanics/Molecular Mechanics (QM/MM hereon) Martí et al. [52] delve deeper
in the NP4 NO release mechanism and show how the Fe-NO affinity plays no
role in the differential release rates, whereas the pH-triggered conformational
changes affect the exit pathways of the ligand as a reversible trap.
In order to better understand the stabilization of the ferriheme, Berry et al.
[53] use wt NP1 and several mutants of NP2 and NP4, with the substitution of
ionizable residues in the heme cavity with non-ionizable ones, and then study
the midpoint potentials and binding constants. The conclusion is that the sta-
bilization of FeIII in NP2 (actually NP2-D1A) "and undoubtedly (in) the other
nitrophorins as well" is achieved via a large number of fairly small contribu-
tions from charged side chains. E53 and D29 seem responsible for a significant
proportion of the lowering of the midpoint potential of NP2-D1A, the other
residues collectively seem to give a significant contribution. L122, L132 and
I120 appear as important for the ruffling of the heme, another factor increas-
ing ferric stability, and for the A:B heme ratio (see also Kubo et al. [54]).
A MD and MSMD comparative study of NP2 and NP4, reported in Swails
et al. [56], concludes that these two members of the NP family share a NO
release control through a conformational change caused by a single conserved
residue’s differential protonation state at different pH, namely Asp30 in NP4,
Asp29 in NP2. But they are also differentiated by the fact that the pH-induced
conformational changes are more extreme in NP4 than in NP2: NP4’s open,
high pH conformation is far more "open" than its NP2 corresponding confor-
mation, and this, in turn, results in the experimentally observed slower release
rates for NP2 than for NP4.
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NP3 NP7 NP1 NP4
NP2 80% 60% 47% 48%
NP3 62% 43% 43%
NP7 40% 41%
NP1 90%
Table 1.1: NP1-4 and NP7 mature sequence identity matrix. (ClustalX)
pI a
NP1 6.35
NP2 6.11
NP3 6.48
NP4 6.35
NP7 9.21
Table 1.2: Comparison of NP1-4 and NP7 calculated isoelectric point. a From
Knipp et al. [58].
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In Knipp et al. [57] NP7 and NP26 are compared in terms of sequence iden-
tity and sequence alignment (see Figure 1.4). In Figure 1.5 proximal His57/60
and all disulphide bridge engaged cysteines are also shown, together with the
secondary structure elements. The paper reports a novel method, the previous
ones being unable to yield sufficient quantities of protein for demanding labo-
ratory use due to precipitation during refolding, for expressing NP7 in E. coli,
purifying it and characterizing it in terms of NO, histamine and liposome bind-
ing properties. NP7 was put in contact with large unilamellar vesicles of PC and
of PC:XX where XX are different phospholipids, always with a 3:1 ratio. Only
when XX is a negatively charged phospholipid (PS, phosphatidic acid, phos-
phatidylglycerol, phosphatidylinositol, cardiolipin) does NP7 bind, while with
neutral lipids no binding is reported (XX being PC, lysoPC, sphingomyelin). In
contrast, none of the other forms NP1-4 does bind with any vesicle at all.
Knipp et al. [58] report the overexpression in E. coli of two variants of NP7:
the recombinant wild type, with expression related M0 (MLPGEC-), and the
∆1− 3 variant, always including M0 (MEC-).
In Table 1.2, the calculated pI of the NPs, as in [57], are reported: a striking
difference is apparent in the isoelectric points.
An analysis about the cleavage of the signal sequence shows that for NP7
6As can be seen in Table 1.1, NP3 actually has the highest sequence identity with NP7, but
the amount of information available on NP2 is far larger than for NP3.
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Figure 1.4: NP1-4 and NP7 sequence alignment. (ClustalX)
Figure 1.5: NP2 and NP7 sequences with secondary structures. Red: His57/60.
Yellow: disulphide bridging Cys’s. Source: Knipp et al. [57].
there is little doubt about the LPGEC- N-terminus, whereas for NP2 and NP3,
up to this point considered as having a 3-residues shorter sequence than NP7,
a suggestion is made that their sequences might actually include an identical
VSG- head.
The conclusions of [58] characterize NP7 as follows:
1. it has the largest difference in NO association constants between high
and low pH (see Table 1.3) ;
2. it has a small histamine affinity, that suggests that, unlike the other NPs,
NP7 does not contribute in vivo to histamine sequestration (see Table
1.3);
3. it has large 1H NMR chemical shifts for the FeIII form;
4. it strongly favours the A orientation of the heme, unlike all other NPs;
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log10 K
III
eq (log10 M
−1)a EoNO (mV vs. SHE)b
NO histamine NO
pH 5.5 pH 7.5 pH 7.5 pH 5.5 pH 7.5
NP1 6.92 6.1 8.0 +154± 5 +127± 4
NP2 ∼ 9.0 8.3 8.0 +49± 3 +8± 3
NP3 7.0 7.60 +73± 1 +13± 1
NP4 7.30 6.92 8.18 +94± 5 -c
NP7 >9 6.6 5.0 +94± 5 +109± 7
NP7(∆1-3) 8.2 ∼9.0 7.1 +157± 3 +228± 4
Table 1.3: Comparison of NP1-4 and NP7 experimental properties. a Equilib-
rium constants from Knipp et al. [58]. b Standard reduction potentials from
Yang [59]. c not measurable for facile dissociation.
5. it has a unique LPG N-terminal sequence which contributes significantly
to the protein fold stability and to the protein functionality.
Another interesting property exposed in He and Knipp [60] is the catalysis
of the reaction
3NO−2 + 2H+→ 2NO+ NO−3 +H2O
that takes place at the ferriheme centre of NP7, suggesting that NP7 may act
not only as a NO transport protein, but also as a NO producer. This reaction is
dealt with in He et al. [61] through UV-visible absorption spectroscopy, electron
paramagnetic resonance, resonance Raman spectroscopy and stopped-flow ki-
netic measurements on NP7 and NP4.
In Yang et al. [55] the peculiar role of Glu27 is investigated. Glu27, as can
be seen in Figure 1.4, is only present in NP7, where in NP1-4 there is uniformly
a valine. By studying NP2, NP2(V24E), NP7, NP7(E27V) and NP7(E27Q) the
key role of Glu27 is identified, as its presence, in terms of steric clash since
Gln27 has the same effect, is the key to the peculiar orientation of the heme (A)
unlike all other NPs. Another feature is here reported, inferred by the different
stability shown by NP7 and NP7(E27Q), that E27 must possess a pKa < 5 and
be therefore always charged, both at high and low pH.
In his doctoral thesis Yang [59] focuses on the characterization of NPs via
NMR spectroscopy. In particular NP7 is studied in comparison with NP2. Some
of the important results that are here mentioned are:
• in NP2(V24E) there are dramatic changes in the heme A:B ratio with pH,
and they are explained in terms of changes in the protein structure in the
vicinity of Glu53, which gets neutralized at low pH;
• the LPG sequence at the N-terminus stabilizes the fold of NP7 as ab-
sorption spectroscopy studies show that irreversible protein aggregation
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starts at about 45 ◦C for the NP7(∆1− 3) variant in front of the 52 ◦C of
the wtNP7;
• dynamic light scattering experiments show that unlike NP2, which is es-
sentially free of oligomers, NP7 contains a large fraction of oligomers;
• judging from NO binding constants (see Figure 1.3) it would seem un-
likely for the NP7(∆1 − 3) variant to be able to release NO in blood
plasma; also from reduction potentials (see again Figure 1.3) it would
seem likely that the ferriheme might be reduced to ferroheme and this in
turn would make NO release impossible; kinetic data (Table 1.4) show
for the variant a very fast kon, setting it apart from all other structures;
• therefore the presence of the LPG sequence at the N-terminus appears to
have an important impact on the protein’s functionality; all the same the
presence of the M0 residue must be noticed in all recombinant structures
(including the NP7(∆1−3) variant), and it is known that such residues in
other NPs have an impact in the A:B heme ratio; e.g. in NP2 (see, beside
the papers already cited, Berry et al. [62]) the addition of M0 causes such
ratio to pass from ∼1:20 to 1:8; the importance of such residue must still
be evaluated correctly for NP7;
• the NP7(E27Q) mutant precipitates at high concentrations (1mM) and
could not be studied by NMR spectroscopy;
• spectra seem to indicate that the presence of Glu27 might induce some
exchange process in the protein structure;
• through circular dichroism NP7(E27Q) is detected to have the same heme
A preference as the wtNP7 and NP2(V24E); mixed species are detected
in NP7(E27V); nonetheless, the NP7(E27Q) is much less stable than the
wt, and this suggests the importance of the Glu27’s charge for the protein
fold, whereas it is the steric properties of Glu/Gln27 to be important in
the selection of the heme type;
• since the NP2(V24E) mutant has a peculiar pH-dependent heme A:B ra-
tio, the suggestion is proposed that the structural rearrangement, in this
case, is controlled by the protonation state of Glu24; this suggestion has
a particular importance for NP7, as the latter is the only family member
with a charged residue in the position where all the others have a valine.
Knipp and He [63] list and describe in some detail the various functions
the NPs have been found responsible for:
NO transport and release: it seems the most straightforward, but considering
that the NO concentration in vertebrate blood lies in the nM range, at
least one of the NPs, namely NP2 (see Table 1.3, remembering that KD =
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koff (s
−1) kon (106 M−1 s−1)
NP1 2.2±0.1 1.5±0.1
NP2 0.12±0.01 33
NP3 0.08±0.01 6.7
NP4 2.6±0.1 2.3
NP7 0.61±0.13 2.4
NP7(∆1-3) 0.50±0.02 ∼500
Table 1.4: Comparison of NP1-4 and NP7 kinetic properties at pH 7.5. Source:
Yang [59].
K−1eq , see also Table 1.4 for the tissue pH kon and koff values) would find
releasing NO in the host’s vessels quite a hard task;
histamine scavenging: this is the only other generally accepted functionality
all NPs seem to have in common; yet, from experimental data (see again
Table 1.3), it seems that NP7 has too low an equilibrium constant to be
able to sequester histamine from the host’s bloodstream; it appears then,
up to this point, that the considerable translational expense for NP7 is
just worth a 1:1 NO:protein release;
catalysis of NO formation from nitrite: this is apparently a functionality that
NPs are able to perform in vivo and at neutral pH; further research is re-
quired to understand whether the ordinary blood concentration of nitrite
ion is sufficient to be exploited by NPs, and how well, differentially, by
the various members of the family;
interaction with high molecular weight blood components: two such com-
ponents have been identified so far, corresponding to two different mem-
bers of the NP family:
1. NP2 is reported to be able to directly interact with factor IXa, thus
inhibiting the subsequent assembly with intrinsic factor Xase com-
plex on the surface of anionic platelets; even if not all details of
this interaction are known, this anti-blood-coagulation action was
among the first to be identified in uncharacterized samples of Rp
saliva;
2. NP7 is reported to be able to interact with the negatively charged
(PS-bearing) external membrane of activated platelets; since the
exposure of PS in activated platelets is related to the assembly of
coagulation complexes and to the clearance of apoptotic cells by
macrophages, this peculiarity of NP7 may allow it to target NO re-
lease on-site without risk of loss due to diffusion and blood flow,
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and at the same time to reduce the negatively charged, coagulation-
cascade-relevant areas on activated platelets.
In Knipp et al. [64] the two Cys-Cys disulphide bridges (C5-C124, C42-
C173) are investigated as possible redox active centres.
In He et al. [65] the loss of proximal histidine coordination only detectable
in FeII-NP7 and FeII-NP2(V24E) is studied as an effect of structural tension
caused by the position of Glu27/Glu24 in NP7 and NP2(V24E) respectively.
Abbruzzetti et al. [66] report an extensive analysis of the FeII-CO (used as a
model for the isoelectronic FeIII-NO, because the slower CO binding and release
rates make kinetics easier to follow) binding and release kinetics performed on
NP4, NP4(D30N) and NP7 at the two in vivo-relevant pHs, through laser flash
photolysis combined with FT-IR and RR spectroscopy, X-ray crystallography and
stopped-flow kinetics.
For NP4, these studies show that there are two Xe cavities which are not
populated by CO at cryogenic temperature, but become populated at room
temperature, with a larger population at pH 7.5 than at pH 5.5, during LFP
experiments. The kinetic scheme adopted to fit the data is reported in Figure
1.6 for both NP4 and NP7. In NP7 at least three reaction intermediates are
found, corresponding to three Xe cavities. When CO is docked in these cavities,
it can remain there for long times, especially at pH 5.5: this is an evidence of
the particular efficiency of NP7 in storing CO (NO).
Whereas for NP7 at all pHs and for NP4 at pH 5.5 no heterogeneity was
shown, the behaviour of NP4 at pH 7.5 must keep into account the coexistence
of two conformers, one "open" (o) and one "closed" (c), apparent both in the
high resolution crystal structures and FT-IR measurements.
Therefore, combining NP7’s effective ligand in-cavity storage capabilities
and its family-unique membrane binding feature, the hypothesis that one of its
main functions might be to release NO at the activated platelet’s surface, or
near it, arises.
In [67] a four-states model to understand the pH-induced conformational
transition for NP4 is proposed. Through Constant pH Molecular Dynamics, a
pKa evaluation for Asp30, the residue whose protonation state is considered the
conformational switch, is obtained, with values of 8.5 and 4.3 for the closed
(pH = 5.5) and open (pH = 7.5) conformations respectively. The proposed
model offers an agreement with the experimentally observed pKa of 6.5 in
terms of dissociation or association and consequent conformational relaxation.
While recombinant NP7 was available since earlier, it was only in 2012
with Ogata and Knipp [68] that a crystal structure, and therefore a pdb file
usable for Molecular Dynamics, was obtained. It must be said, though, that the
homology model built for NP7 is in excellent agreement with this novel crystal
structure.
In Knipp et al. [69] a method is described to detect the native N-terminus
sequence for NP7. The method focuses in the selection and isolation of NP7
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Figure 1.6: NP4 and NP7 LFP kinetic scheme. Source: Abbruzzetti et al. [66].
from Rp’s saliva: the concentration of NP7 is quite low, but taking advantage of
the protein’s unique membrane binding feature it is possible to remove other
NPs, all with a similar molecular mass, and then proceed with mass spectrom-
etry. This method was able to confirm the difference between the recombi-
nantly expressed NP7, with N-terminus M0− LPGEC5− and the native, saliva-
extracted NP7, with N-terminus LPGEC5−.
Finally, Varghese et al. [70] report a ssNMR study on NP7 precipitates, con-
cluding that in concentrations between 0.1 mM to 2 mM oligomers are in equi-
librium with monomers. The preferential oligomerization is in trimers, hex-
amers and higher unidentified oligomeric states. At higher concentration, no
monomers are detectable. The fact that in Rp’s saliva the concentration of NP7
is quite low and not yet quantified leaves the question open as whether NP7 is
found there in monomeric units or at least in part oligomerized. Apparently,
though, the structural properties of NP7 in oligomers are preserved. The study
is an important step towards the employment of ssNMR where solution NMR
or X-ray crystallography are of no use.
1.4 Open questions about NP7
This being the general picture, there are still a few points concerning NP7 that
seem to require particular attention, in order to clarify aspects not well under-
stood as yet. In particular:
from a structural point of view, how the differences with the other NPs in
terms of kinetics are related to the structure and protein fold; how the
length and composition of the N-terminus affects the protein structure
and cavity network; how the conformational pH-controlled changes are
achieved; whether the interaction with a membrane of such rigid β-barrel
shaped protein affects or not the overall protein structure, and if it does,
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how; what is the role for the protein fold and its conformational changes
of the family-unique Glu27 residue;
from a functional point of view, what differentiates NP7 from the other NPs,
what is the aim of the membrane recognition, how it is connected to the
NO-release function that seems well established for all NPs.
It is to address these points that the research efforts described in the present
thesis are meant, in particular using in silico techniques, described in Chapter
2.
In Chapter 3 the results published in Oliveira, Allegri, Bidon-Chanal, Knipp,
Roitberg, Abbruzzetti, Viappiani, and Luque [71] are presented about ligand
migration in NP7 and NP7(∆1-3).
In Chapter 4 some results about the NP7(E27Q) mutant are shown, which
give the opportunity to offer a consistent interpretation of the role of Glu27 for
the NP7 fold.
Finally in Chapter 5 the results of MD simulations of NP7 interacting with
a phospholipidic bilayer are presented which, in connection with NMR spec-
troscopy data, suggest that the membrane interaction might be an evolutionary
strategy aimed at triggering a delayed NO release into the victim’s bloodstream.
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Chapter 2
Molecular Dynamics methods
2.1 Dealing with complexity - the classical way
The high number of atoms of typical protein systems1 makes a full quantum
mechanical treatment of the system impossible at present. Molecular modelling
has overcome this impossibility by means of a variety of methods differing in
terms of nature, depth and width of their approximation.
MD belongs to the family of classical methods. These are a set of tech-
niques having in common the description of the atoms of biologically rele-
vant molecules as point-masses parametrized with quantities such as fractional
charge and van der Waals radius, and chemical bonds as springs connecting the
atoms. The forces these atoms are subject to are therefore classical ones. This
type of approximation proves accurate within the boundaries of phenomena not
involving important redistributions of the electronic density of the molecules,
such as the formation and breaking of chemical bonds (see [72]).
The fundamental requirements for such a classical description on a molec-
ular basis are two [73]:
1. the representation of the energetic contributions as effective additive po-
tential energies associated to simple forces
2. the transferability of such potential energies.
The first one implies that the force acting upon each atom is given by the
classical equation
F(r) =−∇U(r)
where U(r) is the potential energy given by a sum of contributions:
1NP7: 2881 atoms for the peptidic chain, 75 for the cofactor+ligand chain; within a typical
69Å cubic solvent box including water and counterions the atom count reaches 30k. The system
including a phospholipidic bilayer used in Chapter 5 is composed of more than 110k atoms.
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U(r) =

Ubonded(r) +

Unonbonded(r)
The bonded potential energies include all energies related to the displace-
ment of bond distances, angles, dihedrals from their equilibrium value, whereas
the nonbonded potential energies are usually limited to the coulombic electro-
static interactions and the van der Waals ones.
The second fundamental requirement implies that experimental data or pa-
rameters obtained through quantum-mechanical calculations can be used to
develop the full expression of the model potential energy.
2.2 Force fields
The expression force field is used to define the set of parameters and equations
needed to give a full evaluation of the potential energy of a molecular system.
There are several force fields, differing basically for the number and types of
terms included and the origin of the parameters required. Naturally, the main
features are the same: harmonic potentials for bond lengths and angles, Fourier
series for torsions, and the nonbonded potential energy generally includes a
coulombic and a Lennard-Jones contributions.
AMBER [74] and CHARMM [75] are force fields belonging to the same
class: the expressions of the potential energy are very similar, the differences ly-
ing in the definition of some of the parameters. In what follows, the CHARMM
force field will be used as reference mainly because it is the one that has been
extensively used in the studies the next chapters are about. More in-depth
information can be found in [76].
State of the art force fields are generally all-atom models: all atoms, includ-
ing hydrogen atoms, are explicitly represented in the model. Some of the force
fields also allow the representation of lone pairs. The shortcomings of additive
force fields are mainly to be found in relation with the impossibility to fully
account for electronic polarization, especially in a polar condensed phase envi-
ronment such as an aqueous solution. New generation force fields are currently
under development which take into account these effects.
2.2.1 Bonded potential energy terms
The bonded potential energy terms include 2-, 3- and 4-body interactions to
model covalently bonded atoms.
Ubonded(r) =

bonds
Ubond +

angles
Uangle +

dihedrals
Udihedral
The two-body interaction simulates the harmonic vibrational behaviour of
the bond’s length:
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Ubond = k

ri j − r0
2
where k is the spring elastic constant (actually, its double), r0 is the equilib-
rium distance and ri j is the dynamical distance between atom i and atom j,
covalently bonded.
The three-body interaction describes the angular harmonic vibrational mo-
tion occurring between atoms i, j and k, covalently bonded with j in the mid-
dle:
Uangle = kθ

θi jk − θ0
2
+ kub
 
rik − rub2
with, in the first term, kθ being the angular spring elastic constant (again,
actually its double), θi jk the dynamical angle between vectors ri j = r j − ri
and rk j = r j − rk, and θ0 the equilibrium angle; the second term is the Urey-
Bradley term, a correction accounting for the 1-3 nonbonded cross interaction
determined by nonzero values of kub.
The four-body interaction approximates torsional harmonic vibrational mo-
tions between the plane of atoms 1-2-3 (i jk) and the one of atoms 2-3-4 ( jkl):
Udihedral = kφ

1+ cos
 
nφ −δ+ kω  ω−ω02
where the first term involves "proper" dihedrals, with kφ as the (double of
the) elastic constant, n controls the periodicity of the function, δ the phase
shift; the second term accounts for the improper dihedral angles, that is out of
plane bending (dynamical angle ω, equilibrium angle ω0, double of the elastic
constant kω), necessary to preserve planarity and chirality.
In terms of computational complexity, all the bonded terms contribute with
O(N) terms in the summations.
2.2.2 Nonbonded potential energy terms
The nonbonded terms include the long-range interactions between all pairs of
atoms, possibly excluding those couples already involved in covalent bonds:
Unonbonded(r) =

i ̸= j
Ucouli j +

i ̸= j
ULJi j
The first term is the coulombic energy:
Ucouli j = ε14
Cqiq j
ε0ri j
with ε14 being a scaling factor usually kept equal to 1 except when the two
involved atoms are separated by three covalent bonds, in which case their di-
hedral torsions are already computed and the electrostatic interaction can be
scaled down with 0 ≤ ε14 ≤ 1; C , ε0, qi and q j are the Coulomb constant, the
22 CHAPTER 2. MOLECULAR DYNAMICS METHODS
dielectric constant and the values of the two fractional charges borne by the
atoms involved.
The second term is a 12-6 Lennard-Jones potential energy accounting for
the weak dipole attraction at larger distances, and strong hard core repulsion
at short distances:
ULJi j =
 −EminRminri j
12
− 2

Rmin
ri j
6
where Emin is the depth of the energy well, U
LJ
i j
 
Rmin

.
As far as computational complexity is concerned, long range two-point in-
teractions contribute with O(N2) terms to the summations, therefore deter-
mining the overall computational cost. The Lennard-Jones potential, though,
because of its fast fading with distance, is often truncated beyond a cutoff dis-
tance. The coulombic potential energy can be truncated as well beyond a cutoff
(if both are truncated, the computational cost is reduced to O(N)), but as its
dependency on distance is ∼ r−1, fading much more slowly than the LJ poten-
tial energy, this can lead to inaccuracies in the model. One way to overcome
this is setting a large cutoff distance and using switching functions to have a
smooth transition from the full-strength electrostatic potential to zero. Other
ways include fast algorithms, such as the Particle Mesh Ewald algorithm, able
to reduce the computational cost to O(N log N) or lower, with higher accuracy
than simple truncation.
A key point for the precision of the results obtained through the applica-
tion of a given force field is the accuracy of the force field parameters. Both
experimental and computational techniques can be used in order to obtain said
parameters. Among the former, infrared and Raman spectroscopy must be men-
tioned, whereas the latter consist in quantum-mechanical calculations.
An account of the parametrization for the AMBER force field can be found
in Bidon-Chanal [77]. As for the CHARMM force field, the reference work is
[78].
2.3 Molecular Mechanics and Molecular Dynamics
Two important techniques that make use of the force field approach are Molec-
ular Mechanics (MM hereon), and MD. The main difference between them is
the inclusion of time as a dynamical variable in the latter.
MM techniques explore the configurational space of biomolecules in search
of global or local energy minima, i.e. stable configurations, regardless of time
evolution.
It was in the 1950s that MD methods started to be developed. Alder and
Wainwright [79] used this technique to simulate the evolution of a system of
rigid spheres interacting with elastic collisions. During the following decades,
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thanks to the increase in computing power and the improvements in comput-
ing techniques, MD simulations became essential tools in molecular modelling,
taken by themselves or in coordination with smaller scale quantum mechanical
methods2.
MD allows to obtain structural, thermodynamical and kinetic information
about biomolecules and related processes, such as conformational changes,
protein folding, formation of proteic complexes, relationship between structure
and functions, among others.
The starting point for MD is structural data about the molecule of interest,
i.e. spatial coordinates of each atom of the molecule. Once the starting struc-
ture is known, applying Newton’s laws a trajectory is obtained containing the
different conformations the system occupies along the simulation time.
2.3.1 Integration algorithms
The time evolution of the system after a small finite interval ∆t, once the co-
ordinates x ( t¯) are known at a given time t¯, can be expanded in a Taylor series
as
x ( t¯ +∆t) = x ( t¯) + x˙ ( t¯)∆t +
1
2
x¨ ( t¯)∆t2 + o

∆t2

Truncating the series at the second order and disregarding the higher terms,
only the positions, velocities and accelerations at time t¯ appear in the approxi-
mating polynomial. Positions at time t¯ are known and while accelerations are
related to the dynamics of the system through Newton’s second law,
x¨ ( t¯) =− 1
m
∇V (x ( t¯))
in order to calculate the time evolution of the system, velocities at time t¯ need
to be evaluated as well, by a random assignment compatible with the thermo-
dynamic conditions of the system.
Clearly, the system is an example of a many-body problem, and an approx-
imate, numeric solution is the only possible way to deal with it.
Both the AMBER suite [80] and the NAMD program [76] use the so-called
leapfrog velocity Verlet method for integration. The NAMD version of the
leapfrog is described next.
Given the position xn, velocity vn and acceleration an at timestep n, the
following equations are used to obtain values for the next step:
2The coordination of classical MD methods and quantum mechanical models was awarded
with the 2013 Nobel Prize for Chemistry to three pioneers of such multiscale models, Martin
Karplus, Michael Levitt and Arieh Warshel.
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vn+ 1
2
= vn +
∆t
2
an
xn+1 = xn +∆t · vn+ 1
2
an+1 =− 1m∇V
 
xn+1

vn+1 = vn+ 1
2
+
∆t
2
an+1
It is apparent that a very important role is played by the duration of the
elementary timestep ∆t. On the choice of this parameter, the precision and
the computational load of the calculations depend, therefore the choice of the
timestep is a compromise choice between contrasting needs.
The basic requirements is that the elementary timestep should be smaller
than the characteristic times of the fastest motions the simulation is supposed
to capture. Since these are the bond vibrations of light atoms, with frequencies
about 1014 s−1, the elementary timestep should be in the femtosecond range.
A 1 fs timestep means 106 iterations in order to simulate 1 ns. In order to
alleviate some of the computational load, some algorithms have been devel-
oped which apply constraints to the system and allow to enlarge the timestep
duration. One of these algorithms, SHAKE [81], fixes the bond lenghts involv-
ing light atoms (i.e. hydrogen atoms), allowing then to disregard their vibra-
tional motions and to start evaluating with those of angles and torsions of light
atoms, characterized by a lower frequency (∼ 0.5×) and, finally, making a 2 fs
timestep accurate enough. NAMD also makes use of an analytical constraint al-
gorithm, SETTLE [82], to exclude vibrational motions of water molecules from
the calculations.
2.3.2 Simulation conditions
The starting point for any simulation is always an initial configuration. This can
be retrieved experimentally, through X-ray diffraction of crystals or NMR anal-
ysis of solutions, or guessed and modelled based on homology with molecules
with similar composition.
Likewise, velocities must be assigned to each atom, and this is usually done
randomly following a Maxwell-Boltzmann distribution so that the resulting to-
tal kinetic energy corresponds to the target thermal energy at the working tem-
perature.
Finally, the simulation conditions must be specified somehow, the fixable
variables being the number of particles (N), volume (V ), temperature (T),
pressure (P) and total energy (E). According to the choice of which variables
are constrained, different ensembles are defined:
• microcanonical (NVE)
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• isothermal-isobaric (NPT)
• canonical (NVT)
The most common ensembles in protein MD are NPT and NVT.
While keeping N and V constant is achieved in a most natural way, being
these variables directly controlled in the model, the conditions on T and P
require specific algorithms.
As far as temperature is concerned, one option is rescaling velocities ap-
plying the right factor to keep the overall kinetic energy at values within a
certain range of the value that expresses the target temperature. Other op-
tions create a temperature coupling of the system with an external thermostat
(thermal bath), acting as external thermal energy tank, subtracting or adding
energy to the system as needed, by rescaling velocities at every step in func-
tion of the temperature difference between the bath and the system. The most
common methods of this type are the Berendsen [83] coupling and the Nosé-
Hoover [84, 85] coupling. Another option is to introduce friction with solvent
molecules and random effects via Langevin dynamics.
The methods regarding pressure control are similar to those for tempera-
ture control and follow the same principles: the Berendsen barostat introduces
a weak coupling with an external bath using the principle of least local per-
turbation. A Langevin piston [86] is the application of Langevin dynamics to
pressure control, using different kinds of barostats, of which the Nosé-Hoover
one is frequently used.
Simulating infinitely large systems with long range potentials is obviously
impossible. The systems are necessarily confined in a finite space; the larger
the more computationally demanding (the number of interacting couples is
N (N − 1) raising the complexity to ON2), but also the smaller the more
affected by boundary effects. In order to be able to reproduce macroscopic
properties in a MD simulation, the interactions with the boundaries of the con-
fined space must be eliminated somehow, a "somehow", though, that must be
aware of the complexity issues and keep the computational load under control.
A way to eliminate boundary effects is the use of periodic boundary condi-
tions (PBC hereon). The system is confined in a barrierless box that is replicated
in each direction in space. During the simulation, if an atom leaves the central
box crossing one of its boundaries, the atom’s image belonging to the opposite
neighbouring box will automatically enter the central box, keeping constant
the number of atoms. Of course the box must be large enough to avoid self-
interaction of the main molecule with its own image in neighbouring boxes,
especially if the main molecule is charged or has an electric dipole moment.
If PBC allow for finite, albeit "large enough", systems without boundary ef-
fects, the other side of the problem, i.e. limiting the computational complexity
can be achieved only partially, as previously mentioned (see 2.2.2), through a
cutoff in the evaluation of nonbonded interactions. The minimum image con-
vention, prescribing that the longest cutoff is no longer than half the shortest
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box vector, takes care of the self-interaction problem. But the electrostatic po-
tential decays too slowly for a cutoff to be an accurate way to reduce the com-
putational load. The most common method used to avoid this problem is the
Ewald sum method [87]: the sum of all electrostatic interactions is arranged in
two terms with faster convergence, the first including short range interactions
(direct space) with a modified coulombic potential, and the second including
the rest in Fourier space. Such method can be further improved by using Fast
Fourier Transform on a discrete lattice in space (PME, [88, 89]).
2.4 Analysis techniques
2.4.1 Structural analysis
As the result of a MD run is a trajectory composed of snapshots collected regu-
larly (e.g. every 1 ps simulated time), plus some physical quantities are calcu-
lated and saved by the simulation program with similar periodicity in auxiliary
files, the amount of information that can be extracted and processed during or
after a MD production run is enormous. In what follows, only the most relevant
analysis performed in the context of this work shall be described.
The simplest and most immediate to analyse is information about the struc-
ture and the geometry of the molecule: RMSD, RMSF, distances, angles, etc. . .
Usually the calculation of the RMSD is the first step of trajectory analysis, as
it provides information about structural stability, and therefore on the necessity
of extending the MD run to a longer simulated time in order to achieve a more
stable situation. The RMSD on a trajectory can be calculated with a variety of
programs. In the present study, the tools that were used are the ptraj pro-
gram, included in the Ambertools suite [80], and the RMSDTT extension
of VMD [90]. It is calculated as a function of simulated time τ j as follows:
RMSD

τ j

=
 1
Nsel
Nsel
i=1

xi

τ j
− xrefi 2
where Nsel is the number of atoms included in the selection of interest (e.g.:
backbone atoms of the whole protein, heavy atoms of the cofactor, etc.), xi

τ j

is the position vector at time τ j of the i-th atom of the selection, and x
ref
i is the
position vector of the same atom in the structure used as reference, which
could be a chosen frame of the same trajectory, an average structure obtained
from the same trajectory or another structure (e.g. the X-ray one) provided it
is alignable with the trajectory’s structure. RMSD(τ j) vs τ j plots are usually
quite informative about the quality of the simulation.
RMSF (root-mean-square fluctuations) provide a complementary point of
view, as they present the same information about deviations of the positions of
selected atoms from their average positions in a reference structure, this time
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as a function of atom number, or residue number and averaged over simulation
time.
RMSFi =
 1
nframes
nframes
j=1

xi

τ j
− xrefi 2
RMSFby resk =
1
i wik
natomsk
i=1
wikRMSFi
where RMSFi is the RMSF of the i-th atom vs a reference structure, RMSF
by res
k
is the RMSF of the k-th residue as a (weighed) average of its atoms, nframes is
the number of frames included in the calculation, natomsk is the number of atoms
forming the k-th residue and wik is a weight that is null if the i-th atom does
not belong to the k-th residue, and is equal to some non-zero value (usually
the mass of the i-th atom, or simply 1) if the i-th atom does belong to the k-th
residue.
RMSF plots show the different mobility of parts, secondary structures, do-
mains of the protein and provide information useful to refine the RMSD analy-
sis.
Other geometrical and structural quantities that can be monitored over sim-
ulated time or over frequency in a trajectory include bond distances, angles and
dihedral angles: obtained usually through the application of the same programs
mentioned above, they provide information about the persistence of certain
structural arrangements (e.g. short distances between nonbonded atoms that
might suggest the presence of hydrogen bonds or salt bridges), helping to iden-
tify, in turn, the role of some residues in the protein fold or the occurrence of
conformational changes.
Another interesting type of analysis involves the "closest waters" procedure,
implemented in ptraj. It is a way to monitor whether during the trajectory
there are water molecules that remain constantly near some specified residues
or not. That is, to check if there are water molecules that are stably bound to the
protein, as this has an important role in neutralizing residue charge or polarity,
in creating multiple fold-affecting bonds, in occluding tunnels and cavities. The
procedure requires the creation of a structure with only a reduced number of
water molecules, e.g. 20 out of several thousands, used as labels for the same
number of water molecules that, frame by frame, happen to be nearest the
specified residue(s) that need to be monitored. This way, even if the water
molecules, thanks to their high mobility, are moving around the water box and
the actual "identity" of those near the monitored residue changes constantly, the
reduced number of labels is always assigned to those molecules in the vicinity of
the sidechain of interest, and distances over time can be calculated and plotted
in order to point out regularities.
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2.4.2 Pocket detection
MDpocket [91] is a software that applies the fast geometrical algorithm fpocket
[92] to MD trajectories in order to characterize pockets and cavities in proteins.
Fpocket, in turn, makes use of Voronoi tessellations and α-spheres.
MDpocket is applied to a set of aligned snapshots from the MD trajec-
tory; it generates a grid including all the superposed structures, and it as-
signs α-spheres of given maximum and minimum radii to each grid point. This
produces a frequency map of the occupation of the grid point, indicating if
the point is permanently accessible, transiently accessible or permanently hin-
dered.
Some auxiliary python scripts allow the generation of coordinate files in-
cluding the cavity surfaces at the desired isovalue.
The application of MDpocket on subsequent segments of the same trajec-
tories gives information on the geometrical cavities and pockets, on their per-
sistence. This method can be complemented with ILS (see 2.4.3) to include
energetic information.
Typical settings for MDpocket are reported in Table A.3.
2.4.3 Implicit ligand sampling
Implicit Ligand Sampling (ILS) [93–95] is a technique that allows to estimate
the energetics of ligand migration through the protein. By calculating the po-
tential of mean force on a sample (small) molecule (considered in an adjustable
number of possible spatial orientations) placed in every node of a suitably cho-
sen grid, ILS produces a map that can be used to visualize energy surfaces and
analysed through scripts in order to plot energetic contours of pathways chosen
for the ligand.
An ILS plugin, which was used for all ILS calculations of the present studies,
is included in the latest releases of VMD [90]. Its typical settings are reported
in Table A.4.
2.4.4 Essential dynamics
Structural flexibility is strictly related to protein functionality (see e.g. [96–
102]. Therefore the study of the structural deformation and deformability of
a protein can provide relevant information about the processes involving the
protein itself.
There are a few computational techniques aimed to the extraction of es-
sential deformations from an equilibrium structure. One of them is Essential
Dynamics (ED) [103]. In this case, the deformation modes are obtained by
diagonalizing the positional covariance matrix. In so doing, eigenvectors are
obtained reflecting the nature of the different structural deformation modes,
and eigenvalues which measure the contribution of each eigenvector to the
global variance.
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Having different systems, or a single system in different trajectory seg-
ments, and a comparative study of deformability is required, getting the es-
sential modes allows a direct form of comparison, through a similitude index
[104, 105] obtained as a scalar product of the eigenvectors:
overlap (v,w) =
1
n
n
i=1
n
j=1

vi ·w j
2
where n is the minimum number of eigenvectors necessary to explain a certain
value (e.g. 80% or 90% of the total variance).
Given the character of scalar product, the value of the index will be near 0
when the movements are orthogonal, and near 1 when they have a high degree
of similarity.
A limit of this index lies in the supposition that in two different trajectories
or in two different parts of the same trajectory the same modes would have the
same weights relative to the others, which is not granted. More precise indexes
have been proposed in order to overcome this and other limits [106].
2.4.5 Acidity constant determination
As in NPs pH-driven structural rearrangements happen, and these, in turn, are
likely to be triggered by the protonation states of ionizable residues, methods
aimed at calculating the pKas of such residues are valuable tools. One such
is the Adaptive Poisson-Boltzmann Solver (APBS) software, that can be used
within the theoretical framework provided by Baker et al. [107] and the pro-
cedures described on the APBS website3.
Starting from a MD trajectory, a procedure that can be followed includes
the following steps:
1. creation of a statistically relevant collection of snapshots for each exam-
ined structures;
2. assignment (via other rough evaluation software or standard values) of a
protonation state for all ionizable residues;
3. once chosen the residue whose pKa is the object of investigation (“ob-
jective residue”), creation of a copy of each structure file of the previous
point, with a modified protonation state for the objective residue;
4. conversion of all pdb files to pqr (pdb2pqr utility4) using suitable force
field options and requesting the production of an APBS-input file;
5. insertion of cofactors, ligands or any other part of the molecule whose
parameters pdb2pqr does not include, together with their charges and
radii;
3See http://www.poissonboltzmann.org/apbs/examples/pka-calculations
4See previous footnote.
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6. for each "ionized-objective residue" pqr file, creation of a copy of the
single ionized objective residue extracted from the protein and of a copy
of the whole protein with all the charges of the ionized objective residue
set to zero;
7. for each "neutral-objective residue" pqr file, creation of a copy of the
single neutral objective residue extracted from the protein and of a copy
of the whole protein with all the charges of the neutral objective residue
set to zero;
8. preparation of the input files, one per pqr file including grid dimensions
and lenghts extracted from the pdb2pqr output; the key parameters are
the number of grid nodes and the dielectric constant ε inside the protein;
9. an APBS run on every input file, each loading a different pqr file and
referencing it to its "neutral objective residue" version (or to self);
10. extraction from the APBS output files of the transfer free energies; for
example, should the titratable residue be Aspn (ordinarily charged at pH
7, while Ashn indicates its neutral version):
∆G t rn =

∆G t rprot −∆G t rprot−Asp −∆G t rAsp

−
−

∆G t rprotH+ −∆G t rprotH+−Ash−∆G t rAsh

where ∆G t rprot is the total energy of the "base" whole protein with Aspn,
∆G t rprot−Asp is the total energy of the protein with null-charged relevant
residue Aspn, and ∆G t rAsp is the total energy of the single residue Aspn;
likewise the energies in the second brackets are those including Ashn;
11. calculation of the shift
∆pKa =
∆G t rX
ln 10 · RT
12. calculation of the average and standard deviation on the whole collec-
tion.
This will produce the pKa shifts, that need to be added to the standard
values in order to obtain a pKa prediction.
In Table A.5 typical values for APBS variables, included in the input files
used for the present study, are shown.
Chapter 3
Ligand migration in NP7
The present chapter presents some of the details of the research work that was
presented during the 17th International Meeting “Oxygen-binding and sensing
proteins” (Parma, September 2012) and published in Oliveira, Allegri, Bidon-
Chanal, Knipp, Roitberg, Abbruzzetti, Viappiani, and Luque [71].
3.1 The questions addressed
The aim of the study reported in this paper is twofold:
1. to examine the influence of the three N-terminus extra residues (LPG) on
the ligand association/dissociation properties;
2. to examine the structural and dynamical properties of the "closed" and
"open" states representing respectively the low and high pH NP7 states,
especially with reference to the ligrand migration through the protein
interior.
Both questions are dealt with by combining comparative measurements of the
CO rebinding kinetics to wt NP7 and to the ∆1-3 variant lacking the first three
residues, with MD simulations of native and modified aimed ad providing struc-
tural models useful to interpret the ligand migration properties and shed some
light into the structure-function relationships.
The relevant role of the LPG N-terminus sequence in NP7 has been high-
lighted in [58, 69]. The data shown in Table 1.3, reporting the K IIIeq for NO and
the E0NO, and in Table 1.4, i.e. the kon for NP7, NP7(∆1-3) and NP4 (this latter
does not possess the first three residues found in NP7), suffice to expose why
understanding the role of the leading tripeptide is interesting.
As previously mentioned, the main difference between recombinant (E.
Coli) NP7 and the native wt is the presence of Met0 in the N-terminus sequence
(M0LPGEC5-). Due to the variants’ sequence, both forms NP7(∆1-3) (with se-
quence EC5-) and Met-NP7(∆1-3) (M3EC5-) could be recombinantly expressed.
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The ferroheme-CO complex was chosen instead of the ferriheme-NO because
(see also [66]):
1. the present study is not focused on the association/dissociation proper-
ties of the cofactor-ligand complex, but on the interactions between the
released ligand and the cavity system of the protein;
2. both complexes release a diatomic gas molecule with comparable size
and polarity features, therefore allowing to foresee similar interaction
properties with the inner part of the protein;
3. FeII-CO has a slower binding kinetics than FeIII-NO and this facilitates
kinetic studies.
3.2 Methods
3.2.1 Experimental methods
Nanosecond laser flash photolysis assays were performed in the laboratories at
the Università di Parma on protein samples kept at 20 ◦C and with a 1.0atm or
0.1 atm CO. The absorbance spectra were measured between 10ns and 10ms
after the laser flash. The cited paper provides all the technical details.
3.2.2 Computational methods
Initial model
For lack of experimental structures, the initial structures for NP7, wt and vari-
ants, were obtained by homology modeling upon the NP4 pH conformers; NP2
was also used as a model, with no significant differences. Disulfide bridges
were imposed between Cys5 and Cys124 and between Cys42 and Cys173.
Standard protonation states were assigned to all titratable residues except for
Asp321, considered key in the pH conformational switch, which was therefore
kept neutral at low pH and charged at neutral pH. Following the experimental
results, the heme was modeled in the A orientation (see [58]).
While this study was conducted, diffracting crystals of NP7 were obtained
[68], even though further improvement is still required to elucidate the am-
biguous behaviour of the electron density, which is currently on the way.
1Asp32’s role as the pH sensitive switch of the conformational change was suggested by anal-
ogy with well established NP4’s Asp30: see [35, 40, 50, 56, 67]. Such role has been confirmed
by the crystal structures at different pH displaying structures that are compatible with a hydro-
gen bond between Asp32 and Ile132 in the closed structures, which cannot be formed when
Asp32 is charged at higher pH values. See Figure 3.1.
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MD setup
Several different MD runs were performed, with different initial structures and
different force fields and simulation programs. In particular, the AMBER-11
package [80] with parmm99SB [108] with specific parameters for the CO-
bound heme taken from [109], and the NAMD [76] program with CHARMM22
[78] parameters.
After a 50ns preliminary run on both open and closed structures with the
AMBER-11 package, the final snapshot of each of them was used as a starting
point for two AMBER and one CHARMM extended simulations and for building
the models of the variants.
As the NAMD/CHARMM simulations were taken care of at the Università
di Parma, the focus of the present chapter is especially on them.
The NAMD/CHARMM setup is the same as reported in A.1 (Tables A.1 and
A.2).
Free ligand MD
Pockets and cavities were identified and characterized thanks to MDpocket (see
2.4.2) and ILS (see 2.4.3).
A set of MD simulations with a free NO molecule in selected initial positions
and different (pseudorandom) velocities was run in order to sample the ligand’s
escape routes, traps, mobility inside the β-barrel. The NO parameters were
adapted from [93].
For these simulations NP7 was modeled in the FeII-CO form, as the struc-
tural relaxation of the protein core subsequent to the photolyzation of the lig-
and happens on a longer timescale than the nanosecond scale characteristic of
the ligand motions, and in this view the structure around the ligand when it is
released from iron coordination should still resemble the unchanged carboxy
form.
3.3 Results and discussion
3.3.1 Highlights of the experimental results
The laser flash photolysis results have been interpreted through the kinetic
scheme in Figure 1.6, and the best fits to the experimental data2 allow the
determination of the kinetic rebinding constants shown in Table 3.1.
These results, extending those reported in [66], may suggest that the in-
fluence of the NP7 specific N-terminus tripeptide is negligible. This seems in
contrast with some of the conclusions in [58], specifically about the drastic ef-
fect that the deletion of such tripeptide has upon kon(NO), which is estimated
2The fits were obtained using the ODE15s function and the Minuit (CERN) package within
Matlab 7.0.
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NP7 NP7(∆1-3) Met-NP7(∆1-3)
pH 7.5 5.5 7.5 5.5 7.5 5.5
k−1 (107 s−1) 6.9 6 3.7 6 6.9 6.1
k2 (10
7 s−1) 6.5 10 5.2 13 8.0 16
k−2 (107 M−1 s−1) 9.7 42 6 42 5.9 33
k3 (10
3 s−1) 2.6 0.9 2.6 1.7 2.7 0.97
k−3 (103 s−1) 3 2.3 0.5 0.5 1.6 0.1
kc (10
6 s−1) 8.4 6.2 8.4 8.2 7.1 6.2
k−c (106 s−1) 3 3.1 3 3.1 2.9 3.1
kd (10
6 s−1) 0.88 0.85 0.88 1.6 0.96 6.5
k−d (103 s−1) 7.5 9.3 7.5 4.6 4.7 8.0
Table 3.1: Rate constants based on the kinetic scheme in Figure 1.6 for CO
rebinding kinetics to wt NP7 and variants at 20 ◦C. Error bars are between 10%
and 20%. Source: Oliveira et al. [71].
to have a 250-fold increase. The reasons for this difference are not clear and
deserve further attention, but some clues lie in the following points:
• in [58] kon was determined from Keq and koff; the latter, in turn, was
determined by the replacement of NO with excess imidazole;
• in [20] similar procedures were repeated on NP1-4, and lead to the con-
clusions that the constants obtained through flash photolysis and ligand
displacement can differ even by three orders of magnitude, perhaps be-
cause of a structural relaxation following the replacement;
• different behaviours of the association/dissociation of CO and NO cannot
be excluded in principle, and neither can a different affinity of ferri- and
ferroheme for water molecules in NP7.
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Figure 3.1: Superposition of NP7 average structures o1A, oC (a) and c1A, cC
(b) (see Table 3.2, caption). Regions corresponding to the N-terminus, the
AB and GH loops are shown in magenta, green and blue respectively. Source:
Oliveira et al. [71].
3.3.2 Computational results
Structural analysis
An analysis of the protein backbone RMSD3 reveals differences mainly related
to the N-terminus and the AB and GH loops. The RMSD values are reported in
Table 3.2.
The contribution to the RMSD differences by the N-terminus is obvious:
such segment is not structured and it can interact (mainly via the positive
3In this case, the RMSD is calculated between the structures obtained after 1) averaging the
atomic positions over the last 10 ns of the trajectories, and 2) applying energy minimization pro-
tocols to the average structures. This last step is included in order to get final structures that are
dynamically plausible and that can be used as realistic representative structures of their trajec-
tories, at least for the time window considered in the averaging process. On the other hand, the
energy minimization process affects the statistical features of the average structure, in particular
the one of minimizing the RMSD, in a manner that is a priori unpredictable. Therefore, the
RMSD values calculated between energy-minimized average structures ought to be considered
more as a set, for their values relative to each other, than for their absolute values.
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Figure 3.2: Superposition of NP7 average structures oC and cC (see Table
3.2, caption). Regions corresponding to the N-terminus, the AB and GH loops
are shown in magenta, green and orange respectively. The green and orange
loops are kept close to each other by the Asp32-Ile132 hydrogen bond in the
closed structures, and far apart by coulombic interactions in the open struc-
tures. (VMD)
charge of the N-terminus) equally well with different residues. The role of
the AB and GH loops is also clear, as they are affected by the protonation state
of Asp32. It is possible to visually appreciate such differences by comparing
AMBER and CHARMM average structures of the same type (Figure 3.1) and
CHARMM structures of different types (Figure 3.2).
By excluding the N-terminus and the AB and GH loops from the RMSD eval-
uation (in italics in Table 3.2), the values decrease considerably, and group as
would be expected in homogeneous open (between 1.14Å and 1.53Å), homo-
geneous closed (between 1.05 Å and 1.45 Å) and cross open-closed (between
1.43 Å and 2.11Å).
The RMSD decrease is larger for the open structures, again as expected,
since in the closed structures the AB and GH loops are kept tightly together
by the hydrogen bond between Asp32 and Ile132 (Figure 3.2). The absolute
values of the RMSD, especially those calculated excluding the most mobile seg-
ments, well below 2 Å, suggest that the protein core is stable and rigid, as has
been experimentally shown in previous works (see e.g. [49]) for other mem-
bers of the Nitrophorin family.
Again, the range of the cross open-closed RMSD values after the exclusion
of the most flexible regions is anyway higher than the homogeneous values, and
this justifies to trust that the different force fields have an impact that is lower
than the effect associated with the open-closed conformational variability.
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o2A oC c1A c2A cC
o1A 2.40 1.76 2.63 2.72 2.88
1.44 1.14 1.98 1.43 2.11
o2A . 2.66 2.16 2.28 2.55
. 1.53 1.53 1.43 1.66
oC . . 2.81 2.99 2.81
. . 1.83 1.85 1.83
c1A . . . 1.26 1.44
. . . 1.05 1.19
c2A . . . . 1.81
. . . . 1.45
Table 3.2: RMSD (Å) between the backbones of the wt energy-minimized struc-
tures obtained averaging the last 10 ns of MD trajectories. In italics: RMSD
obtained excluding the N-terminus tripeptide and the AB and GH loops. "o1A"
stands for "open, 1st simulation, AMBER", while "cC" for "closed, CHARMM".
Source: Oliveira et al. [71].
3.3.3 Cavities
In [66], as previously reported (1.3), different kinetic schemes were proposed
for NP4 and NP7 (Figure 1.6). In particular, a more complex scheme for NP7
is to be adopted in order to explain a longer residence of the CO ligand in the
protein interior following photodissociation. In order to better understand the
migration paths followed by the ligand, the identification of the cavity system
within the protein was pursued with MDpocket (see 2.4.2) on subsequent 20ns-
long windows. The reason to choose separate, non-overlapping time windows
(belonging to the same stability regions of the MD trajectories) is the possibility,
which is given in so doing, to verify the reproducibility of the cavities.
Three cavities, shown in Figure 3.3, are found both in the open and in
the closed structures and in simulations run with both the AMBER and the
CHARMM force fields through the MDpocket isocontour frequency maps, al-
lowing to identify how often during a MD simulation segment the cavities are
connected into a single tunnel.
The first cavity (denoted site 1) includes two separate docking sites (1a and
1b), defined by the "back" side of the heme4 and by residues Phe43, Leu58,
Tyr107, Ile123, and Leu125.
The second cavity (site 2), further down the barrel, is delimited by Phe20,
Phe45, Pro47, Glu56, Tyr84, Val109, Ile121 and Leu139.
4In Figure 1.3/A, the "back" side is identified by the α bridge between pyrrols I and II. The γ
side is the "front" side, as the propionates stemming from pyrrols III and IV are protruding from
the "mouth" of the protein’s barrel.
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Figure 3.3: Identification of sites 1, 2 and 3 in NP7 (wt closed structure, iso-
value: 0.75 frequency). (MDpocket/Pymol)
Site 3, further again, is lined by Phe20, Phe21, Val54, Leu77 and Val111.
Most of the cavity-defining residues are hydrophobic (Ile123 and Leu125,
in site 1, also define the ligand cage in the heme distal cavity), with the note-
worthy exceptions of polar residues, and even charged Glu56, all engaged in
interactions that are crucial for the overall protein fold, and thus neutralizing
their polar character (see [110]).
Implicit Ligand Sampling (see 2.4.3) was applied on the same 20ns-long
windows along the trajectories. In this case, the ILS isocontour maps are isoen-
ergetic surfaces.
For the closed wt protein, a continuous linkage between sites 1 and 3 is vis-
ible at an energy isocontour of 3.0kcal mol−1 (see Figure 3.4), which suggests
that a gaseous diatomic ligand should easily exchange between the two sites.
At the same energy value there is no continuous linkage between the same sites
in the wt open protein. Such linkage becomes apparent only at a much higher
energy value, about 15kcal mol−1, which would indicate that a free gaseous
molecule should be mainly confined in site 1 or released to the solvent at high
pH.
These results seem to point out that while in the open form the three sites
only occasionally are connected into a single tunnel running inside the protein
and connecting the heme environment with the "back" end of the barrel, the
presence of such single tunnel, although not constant, is significantly more
frequent in the closed form.
The overall structure of NP7(∆1–3) shows a large resemblance with the
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tunnel cC cC-∆a oC oC-∆a
upper tunnelb 65% 40% 55% 40 %
back tunnelc 70% 60% 50% 45 %
direct exposured 60% 90% 70% 75 %
Table 3.3: Tunnels in wtNP7 and variants. a cC-∆ and oC-∆ are the ∆1− 3
variants obtained with the CHARMM force field from the closed and open wt
structures respectively. b The upper tunnel connects the distal pocket with the
exterior through strands G and H. c The back tunnel connects the distal cavity
with the "back" of the protein along the barrel axis, joining together sites 1, 2,
3. d Direct exposure of the ligand to the solvent through the "mouth" of the
barrel. (MDpocket)
o2A oC c1A c2A cC
o1A 0.77 0.81 0.53 0.53 0.55
o2A . 0.71 0.51 0.49 0.49
oC . . 0.52 0.53 0.59
c1A . . . 0.90 0.76
c2A . . . . 0.81
Table 3.4: Similarity indexes between the inner cavities in wt trajectories ac-
cording to Tanimoto’s distance. Source: Oliveira et al. [71].
wt protein, especially in the AMBER simulations, with RMSD values for the
backbone atoms of 1.52Å and 1.42Å for the open and closed species, respec-
tively. For the CHARMM simulations, the values are higher between the open
structures (3.78Å) and lower for the closed ones (1.19 Å).
The MDpocket analysis also supports the topological resemblance between
the inner cavities in both wt NP7 and its variant. Thus, the Tanimoto’s distances
(see [111]) between wt and NP7(∆1-3) were 0.65 (open) and 0.74 (closed),
whereas the cross (open versus closed) similarity index was 0.54, thus mimick-
ing the trends found for wt NP7 in Table 3.4.
3.3.4 Free ligand diffusion
In order to clarify what the influence of the partially pervious tunnel upon the
ligand migration might be, a set of free ligand MD simulations was run.
In the complete protein-heme-CO structure5 (starting from the last snap-
5The reason for choosing the same NP7:CO structure adding a free NO molecule lies in the
fact that it is most probable that, because of the characteristic times of flash-photolysis, diatomic
ligand motion and protein structural relaxation, a flash-photodissociated NO molecule finds itself
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Figure 3.4: ILS energetic profiles linking inner cavities in the closed (top) and
open (bottom) forms of wtNP7. The isocontour corresponds to an energy value
of 3.0 kcalmol−1. Source: Oliveira et al. [71].
shot of the trajectories for the open and closed, wt and ∆1-3 variants), a single
NO molecule was inserted in four different positions (named A, B, C and D; see
Table 3.5, Figure 3.5), and for each of these four situations, five replicas, dif-
fering in the random seed for initial velocity generation, were produced. Each
simulation covered a 20ns time span, following the ordinary energy minimiza-
tion and equilibration steps.
As far as closed wt NP7 is concerned, the positions sampled by NO in the
interior of the protein reflect the topological features of the cavities identified
from MDpocket analysis. NO molecules primarily populate sites 1a, 1b and
3, whereas a lower occupancy is found for site 2, suggesting a lower effective
in a still unrelaxed protein, i.e. as if the protein conformation was frozen at the heme-ligand
bond breaking instant.
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ID position identifying residues
A end of back tunnel (site 3) 81 15 17
B beginning of back tunnel (site 1) heme 121 123 135 139
C beginning of side tunnel 30 32 37 132 135 heme
D N-term 1 34 36
Table 3.5: Initial positions for free ligand simulations.
pos. A pos. B pos. C pos. D
in2 ex3 in2 ex3 ee1 in2 ex3 ee1 in2 ex3
cwtC 0.8 0.24 0.8 0.24 1.0 1.0
owtC 0.2 0.84 0.2 0.86 1.06 0.2 0.85
(1:3)
c(∆1-3)C 0.8 0.24 1.0 0.2 0.87 1.0
o(∆1-3)C 0.4 0.65 0.8 0.26 0.2 0.86 1.0
(2:1)
Table 3.6: Free ligand exit/residence after 20ns. 1 Exit during equilibration
(no MD run performed). 2 Inside the protein after the 20ns run. 3 Exit during
MD run. 4 Exit only through the “back”. 5 Exit partly through the “back” and
partly through the “mouth”. 6 Exit only through the “mouth”. 7 Exit partly
throuth the “mouth” and partly through a side tunnel (1:3).
volume for accommodating the ligand in this latter cavity. The trajectories that
started from position D led to ligand egression in all cases (see Table 3.6). For
position C, the ligand was either released to the solvent during equilibration
or migrated through the docking sites, and in few cases it was released to the
solvent from site 3 through the back of the protein (near residues Leu15 and
Gly81). Finally, the trajectories started from positions A and B led to either
retention of NO in the interior of the protein (70% of cases) or to egression
through the back of the protein (30% of cases).
The distribution of NO between sites 1 and 3 is well reflected in Figures 3.6,
3.7, obtained by plotting the distribution of distances of the position occupied
by the free ligand molecule (more precisely, by the N atom) from a reference
atom along the trajectory time (i.e. Gly81’s Cα
6). Speaking of the whole set
6The most common choice for such internal distance parametrization is the heme iron atom.
In this case it was not the most suitable one, as the heme undergoes displacements during the
trajectory, while the most reliably rigid part of the system is the β-barrel. Gly81 is obviously a
no-sidechain residue, its position lies on a tight loop at the very “back” end of the barrel, more
external than site 3, and for these reasons its Cα atom was deemed the best choice as a reference
point to parametrize NO’s position in the protein’s interior. In addition, this choice is supported
by the structural similarity of the barrel, which allows to define a common reference frame.
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Figure 3.5: Starting positions of free ligand simulations. The labels refer to
those given in Table 3.5. (VMD)
of simulations (i.e. including both the AMBER and the CHARMM results) the
trajectories started from position A (site 3) sample regions to position B (site
1) and vice-versa. The migration of the ligand between sites 1 and 3 suggests
the existence of small energy barriers for diffusion through the interior of the
β-barrel, in agreement with the linkage between sites 1 and 3 found from ILS
calculations. Finally, the lack of the peak corresponding to site 2 suggests that
it is only transiently populated in the exchange pathway between sites 1 and 3.
Accordingly, site 2 should not be treated as a stable docking site, but rather as
a temporary site that bridges cavities 1 and 3.
For the open wt structures, all the trajectories started from positions B, C
and D released NO to the solvent through the front side (distal cavity) of the
protein, in agreement with the physiological function of releasing NO at the
plasma pH. Only very rarely did NO migrate through the cavities and exited
through the back of the protein (site 3). When the simulations started from po-
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Figure 3.6: Free ligand distance (between NO’s N atom and Gly81’s Cα) dis-
tribution for wt NP7. Closed structure on the left, open on the right. Starting
position A/3: black; starting position B/1: red. Source: Oliveira et al. [71].
Figure 3.7: Free ligand distance (between NO’s N atom and Gly81’s Cα) distri-
bution for NP7(∆1-3). Closed structure on the left, open on the right. Starting
position A/3: black; starting position B/1: red. Source: Oliveira et al. [71].
sition A (site 3), however, the ligand was released to the solvent only through
the back of the protein. In contrast to the closed structures, the ligand is mainly
localized in site 3, indicating the existence of enhanced barriers for ligand dif-
fusion to site 1, in agreement with the larger isoenergy contour required to link
sites 1 and 3 from ILS calculations. This is supported by the larger thermal fluc-
tuations of the residues that define the distinct cavities in the β-barrel, as can
be noticed in Figure 3.8, which compares the RMSF in both open and closed
states. Thus, the lower flexibility of the β-barrel residues in the open state
likely contributes to the larger barrier for ligand exchange between docking
sites.
Free ligand MD simulations run on NP7(∆1-3) using the same set of start-
ing positions and simulation protocol confirmed the results reported for wt
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Figure 3.8: RMSF (Å) for the residues defining the internal cavities of wt NP7.
Cavities 1, 2 and 3 are respectively blue, green and yellow colour-coded. For
each residue, the dark and bright columns refer to the closed and open struc-
tures respectively.
NP7. In particular, the NO distribution profiles confirmed the enhanced diffu-
sion of the ligand between sites 1 and 3 for the closed NP7(∆1–3) compared
to the open species, where ligand migration between inner cavities seems to be
hindered.
Overall, these results allow us to suggest that deletion of the first three
residues at the N-terminus does not introduce drastic structural alterations in
NP7’s cavity system. This supports the existence of a common pattern for ligand
migration in both wt NP7 and NP7(∆1–3), in agreement with the similarity in
the kinetic rate constants reported in Table 3.1.
3.3.5 Comparison with NP4
In [66] two different kinetic schemes for ligand migration in NP4 and NP7 (see
Figure 1.6), are proposed, based on new experimental data and on previous
works (e.g. [52, 56]). In order to verify the extent of the differences in terms of
cavities between the two members of the NP family, the same type of MDpocket
and ILS analysis was performed on NP4 (a more precise account of which can
be found in the [71] paper).
The most relevant difference between the two proteins is that NP7’s site 2
is absent in NP4. This may be interpreted as the combined effect of the variants
Phe20(NP7) ↔ Tyr17(NP4), Val109(NP7) ↔ Phe107(NP4) and Gly75(NP7)
↔ Leu74(NP4). While the two former variations reduce the free space in the
middle of the β-barrel, the latter displaces the position of Glu55 in NP4 (Glu56
in NP7) towards the interior and modifies the positions of Tyr82 and Tyr105
in NP4 (Tyr84 and Tyr107 in NP7), facilitating the opening of a small cavity
between these residues in NP4 (but absent in NP7).
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The lack of site 2 in NP4 should hinder the ligand exchange between the
equivalent of sites 1 and 3 in NP4 compared to NP7. This agrees with the find-
ings from previous MD simulations of NP4 where NO did not migrate to the
interior of the protein, see [50, 52], even though simulations were extended
for more than 100 ns. Furthermore, spectroscopy at cryogenic temperatures
has shown that NO and CO rebinding to the heme occurs exclusively from the
distal pocket [36]. Finally, the existence of the two docking sites in the vicin-
ity of the heme (precisely next the ligand binding site on the distal side of the
heme, and under the heme, in the proximal pocket) may explain the existence
of the two phases seen in the kinetic trace of NO rebinding kinetics to ferrous
NP4, as reported by [38]. While the first phase can be assigned to the rebind-
ing directly from the distal pocket site, the second phase (geminate amplitude
<5%), which is insensitive to the variation of the pH, may be ascribed to mi-
gration of photolyzed ligands to the proximal site.
3.3.6 Functional implications
As shown above, experimental results ([36, 38, 50, 52, 66]) benchmark the
picture provided by the MD simulations: there is a hypothetical kinetic mech-
anism with an extra docking site in NP7; this mechanism can be put in corre-
spondence with the differential availability of docking site 3, reachable from
site 1 via transient site 2 in NP7 but not in NP4.
This suggests that NP7 might be functionally linked to the existence of two
pathways for ligand migration. One corresponds to the release through the
distal cavity, which is greatly enhanced upon transition from closed to open
states due to the breaking of the hydrogen bond between Asp32 and Ile132
(see Note 1 and Figure 3.1), and the concomitant opening of loops AB and GH.
A second pathway would involve the access through site 3 at the back of the
protein, near residues Leu15 and Gly81.
The question has been often raised why Rp provides a bundle of NPs in its
saliva instead of providing just one NP. The various isoproteins seem to address
different targets in the host tissue, but in addition it seems that the proteins
have different mechanisms to provide their load to the specific target. Keeping
in mind that most of the NP7-specific, positively charged residues are located
on the “back” of NP7, and that this protein exhibits the unusual property of
targeting negatively charged phospholipid membranes [33, 57, 58], it can be
speculated that the interaction with the membrane may alter the local structure
at the back of the protein and thus facilitate the exchange of ligands between
membrane and protein through internal diffusion from the heme to site 3.
With regard to the functional role of the NP7-specific N-terminus, the re-
sults do not allow to provide a consistent conclusion. The computational struc-
tural data and also the kinetic data derived from CO rebinding studies do not
disclose fundamental distinct trends between NP7 and NP7(∆1–3). However,
the NO distribution profiles show significant differences and, thus, suggest a
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non negligible influence of the Leu-Pro-Gly tail, as noted in the significant dif-
ferences found in thermodynamic parameters Keq and E
o obtained for both
forms (see Table 1.3).
3.4 Conclusions
Summarizing the main findings already mentioned above, the conclusions that
can be drawn from this section of the research work can be listed as follows:
• the differences caused by the choice of one force field instead of another
are small, probably within the conformational variability allowed for the
protein dynamics by both force fields;
• the existence of three main cavities in the interior of the β-barrel is sug-
gested, which, as expected, are lined with hydrophobic residues; the exis-
tence of site 2 would make the passage between site 1 and site 3 possible
for a small ligand;
• this axial tunnel, even if not permanently defined, is in contrast with
the topology of inner cavities in NP4 and provides a structural basis to
the enhanced internal gas hosting capacity in NP7 and to the absence of
ligand rebinding from secondary sites in NP4;
• site 3 is particularly interesting as it lies at the “back” of the protein,
right where an accumulation of positively charged Lys residues would
suggest the interaction with negatively charged membranes can occur,
and this, in turn, leads to the speculation of an interconnection between
the processes of docking to cell surfaces and NO release, probably via site
3.
As NO delivery through protein-membrane interaction is an interesting hypo-
thetical mechanism for NO signaling, future studies will be conducted in or-
der to verify and define its actual occurrence. The availability of experimental
structural information of NP7 might shed light into the functional implications
of the N-terminus.
Chapter 4
Glu27 and the conformational
transition between open and
closed states
4.1 The questions addressed
In [67] (see section 1.3) through CpHMD a pKa evaluation for Asp30 in NP4
was obtained, ranging between 8.5 and 4.3 for the closed (pH = 5.5) and
open (pH = 7.5) conformations respectively. The proposed model offers an
agreement with the experimentally observed pKa of 6.5 in terms of the degree
of ionization of Asp30 and the consequent conformational transition.
In [55] (see section 1.3) the role of E27, unique occurrence in NP7 through-
out the family where all the other members have a valine (Figure 1.5), was
analysed by mutating this residue to different choices. E27’s role can be set in
relation with the heme’s position and orientation. Since the heme’s position is
one feature that seems to distinguish the open and closed conformations, E27
can ultimately influence the ionization of Asp32, and hence the conformational
transition.
In order to clarify what influence E27 produces upon the protein structure,
an experimental and computational study was performed in order to compare
wtNP7 structures and E27 mutants, namely NP7(E27Q), NP7(E27V) and purely
computational NP7(E27prot) i.e. with E27 modelled as protonated.
4.2 Methods
4.2.1 Experimental methods
Nanosecond LFP assays were performed at Università di Parma on wtNP7 and
NP7(E27Q) at 20 ◦C temperature and 1atm and 0.1atm CO pressure and at
both pH 5.5 and pH 7.5. The experimental assays were repeated extending the
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structure action
E27p1 patch GLUP 271
E27p2 E27:OE1↔E27:OE22, patch GLUP 271
E27Q1 GLU→GLN3, Q27:OE2→Q27:NE23
E27Q2 GLU→GLN3, Q27:OE1↔Q27:OE22, Q27:OE2→Q27:NE23
E27V E27’s sidechain deleted4, GLU→VAL3
Table 4.1: E27p’s and E27Q’s preparation, following hydrogen atoms’ deletion
and preceding the application of VMD’s autoPSF extension to recreate the cor-
rect bonds and place new hydrogen atoms in suitable positions. 1 Forces the
structure-building autoPSF plugin to add a hydrogen atom to otherwise nor-
mally ionized Glu27:OE2 atom. 2 Manual swap between two atom names on
the pdb file. 3 Manual renaming of all atoms of a residue or of a single atom,
in the pdb file. 4 Manual deletion of the sidechain in the pdb file, from Cβ
onwards.
timescale to the ps range by using an ultrafast ps pump and probe set avail-
able at the Politecnico di Milano (Prof. Giulio Cerullo) in order to understand
the geminate rebinding phase and evaluate the rebinding kinetics as a whole,
and therefore also estimate in a more precise way the bimolecular fraction in
different conditions.
4.2.2 Computational methods
Building the structures, getting the trajectories
Starting from a snapshot in a stable segment of NP7c’s trajectory, (see Chap-
ter 3) two versions of NP7(E27p) (named E27p1 and E27p2), two versions
of NP7(E27Q) (named E27Q1 and E27Q2) and one version of NP7(E27V)
(named E27V) were prepared. The reason for the double structure for all vari-
ants except the E27V is the possibility to protonate/mutate either E27:OE1 or
E27:OE2. Therefore the procedure was the following:
i removal of all hydrogen atoms, water molecules, ions in the pdb file of the
chosen frame;
ii actions described in Table 4.1;
iii rebuilding of structure file: application of patches, insertion of the system
in a water box and addition of counterions (A.1.1).
The usual 3-step energy minimization process then took place as in A.1.2,
and after that the 2-step equilibration procedure A.1.3.
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Each production dynamics run, set as in A.1.4, covered 150 ns with 2 fs
timesteps. They were performed by NAMD2.9 on 128 processors in 8ns seg-
ments.
Looking for the acidity constants
The procedure described in 2.4.5 was followed in order to verify the pKa for
Asp32.
1. the collection of snapshots was chosen as 100 frames sampling 10 ns-long
intervals along each trajectory;
2. the standard protonation state at pH 7.0 was assigned to all ionizable
residues and termini;
3. the “objective residue” was Asp32 (Ash32);
4. the CHARMM force field was chosen;
5. insertion of the heme cofactor in all pqr files, coordinates copied in from
the original pdbs, plus the CHARMM parameters (charge, radius), as the
pdb2pqr does not include the heme’s parametrization among its features;
6. for each "Ash32" pqr file, creation of a copy of the single Ash32 residue
extracted from the protein and of a copy of the whole protein with all the
charges of the Ash32 residue set to zero;
7. for each "Asp32" pqr file, creation of a copy of the single Asp32 residue
extracted from the protein and of a copy of the whole protein with all the
charges of the Asp32 residue set to zero;
8. the number of grid nodes was determined in such a way that in the fine
grain step of the focusing procedure the separation between nodes would
be between 0.25Å and 0.50Å, while the dielectric constant ε inside the
protein, suggested as 20 in the APBS tutorials, but changed to other val-
ues during the calibration phase (see below);
9. APBS run on every input file, each loading a different pqr file and refer-
encing it to its "Asp32" version (or to self);
10. the extraction is best done through scripts finding the relevant informa-
tion in the standard APBS output files and copying them onto a single
new file;
11. and 12. the shift, average and standard deviation can be easily calculated
via scripts parsing the file written during the last step.
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A calibration phase is needed in order to verify that the chosen dielectric
constant (ε = 20) is able to provide for NP4 results comparable with those
obtained in [67]. The methodology is thus applied to snapshots from an NP4
MD in the closed configuration on Asp30, and the resulting pKa average shift
are +4.9±0.5, which, added to the model 4.0 value for Asp, should lead to a
pKa of 8.9 for Asp30 in the closed form of NP4, thus providing a close match
with the reference results obtained from CpHMD calculations.
4.3 Results
4.3.1 Experimental results
By combining ps pump and probe with ns flash-photolysis measaurements per-
formed on the carboxy-E27Q mutant (see [55] for more information about the
mutant) it is possible to notice some peculiar trends differentiating wtNP7 from
the E27Q mutant.
In Figure 4.1 the results are shown, where the empty gap in the 1 ns-10ns
region is due to the fact that the pump and probe measurements can be ex-
tended to 1.9ns for the longest, while the ns technique resolution is no lower
than 20 ns.
These peculiar trends that can be extracted from Figure 4.1 are:
1. sub-ns kinetics
wtNP7 the sub-ns kinetics comprises two kinetic phases, whose ampli-
tudes and apparent rates increase at pH 5.5;
E27Q also the sub-ns kinetics becomes faster and larger when the pH is
5.5, but the difference is smaller than for the wt protein; this phase
can be described with two exponential decay functions.
2. bimolecular rebinding
wtNP7 the bimolecular rebinding has a remarkable heterogeneity at pH
= 7.5, with a fast (100µs) rebinding followed by slow, ms lived
decay independent of CO concentration1. At 5.5, the bimolecu-
lar phase is much faster but not less heterogeneous (with lifetimes
30µs and 300µs);
E27Q here too there is a slightly more heterogeneous bimolecular re-
binding kinetics (three exp decay steps are needed, with lifetimes
about 10-50µs, 200µs and 2 ms), but the effect of pH is negligible.
1This slow CO concentration independent decay might be explained in terms of a different
species that is reacting more slowly because of some structural rearrangement, possibly for
the entrance of water molecules in the heme pocket and the consequent competitive effects in
binding.
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Figure 4.1: Comparison of CO rebinding kinetics of wtNP7 (A) and NP7(E27Q)
(B). T=20 ◦C. Blue: pH 5.5, pCO=1atm. Cyan: pH 5.5, pCO=0.1atm. Black:
pH 7.5, pCO=1 atm. Grey: pH 7.5, pCO=0.1atm. Unpublished data.
The different behaviour between the wt and the E27Q mutant in terms of
pH-induced shift shows a definite decrease in the efficiency of the pH switch
and a slower rebinding on the whole.
As far as the geminate rebinding phase is concerned, when the pH is low-
ered ligands find escaping more difficult from the interior of the protein. The
increase in the apparent rate suggests that there may be an increase in the rate
of the rebinding step (CO binding to Fe). This may be mixed to the expected
change in the exit/entry rates due to the conformational consequences of the
pH change. Heterogeneity in the fast rebinding phase (ca. 0.5× 10−10 s and
ca. 0.5× 10−9 s) may mean that there is modulation by temporary docking
sites located near the distal pocket.
About the bimolecular phase, the almost complete loss of pH sensitivity can
be explained in the following terms:
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Figure 4.2: RMSD (protein backbone) against final wtc (at 300 ns) of the vari-
ant structures. (Grace)
1. Glu27’s protonation is crucial to trigger the conformational change (i.e.
it takes part directly as a primary actor in said conformational transition),
so that when Glu is mutated to Gln and the deprotonation cannot happen
the conformational change is made impossible, or
2. Asp32, so far understood as the crucial residue for the conformational
change, undergoes a pKa shift due to the different electrostatics gener-
ated by the presence within the proximal cavity of Glu27 or Gln27.
As Glu27 is reported to be always charged (see [55]), and as some pH
sensitiveness is still visible, hypothesis 2) seems worth investigating.
4.3.2 Simulating the mutants
RMSD and distances
After 150ns of MD, the backbone RMSD profile along the trajectory is shown
in Figure 4.2. During the last 70 ns all forms seem to reach a similar level of
stability, for which the particular rigidity of the β-barrel might be credited.
A measure of the resemblances and differences between the structures is
given by the cross-RMSD values in Table 4.2. Here the energy-minimized aver-
age structures (see below) are overlaid and their RMSD is calculated. Although
it is easy to identify which structure resembles most another, a clear division
in groups is not available and all five structures seem to be part of a gradually
differing single class.
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RMSD (Å) prot2 Q1 Q2 V
prot1 2.203 2.106 1.785 2.438
prot2 - 2.119 2.240 2.207
Q1 - 1.635 1.871
Q2 - 1.821
Table 4.2: Cross-RMSD values for backbone atoms between the energy-
minimized average structures, including N- and C- termini. (VMD-RMSDTT,
see Section 2.4.1)
Figure 4.3: RMSD (heme+CO, heavy atoms) against final wtc (300 ns) of the
variant structures after 150ns. (Grace)
Figure 4.3 shows the heavy atom RMSD for all the mutants’ heme cofac-
tor and CO ligand, upon structure alignment of the protein backbone with the
reference’s (wtc). The average value indicates a common trend for all the sim-
ulated systems but E27Q1, which stands out as peculiar in terms of heme posi-
tioning. This feature shall be dealt with in what follows.
Average structures
In order to collect average structures, the following trajectory intervals were
used, on the basis of the information provided by Figure 4.2:
E27prot1: 140-150 ns
E27prot2: 120-130 ns
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E27Q1: 130-140 ns
E27Q2: 130-140 ns
E27V: 120-130 ns
Submitting the average structures to an energy-minimization process is a
common practice aimed at obtaining average structures that are physically
likely, at least from a steric point of view. This process is described in Ap-
pendix A.1.2. In what follows, then, the reference structures will be the energy-
minimized average ones taken from the time windows as in the scheme above
from each trajectory.
RMSD plots of different backbone selections vs. the energy-minimized av-
erage structures are shown in Figure 4.4. As the black line represents the whole
backbone, the red excludes the first four residues (N-terminus) and the green
line excludes the N-terminus and the AB and GH loops, it is apparent that the
largest part of the RMSD variability is due to the motions of the N-term and
said loops. Apart from the very last part of the E27prot2 and E27Q2 trajecto-
ries, the high degree of stability shown by the green plots (the protein core,
where the β-barrel’s low contribution is predominant) is comparable between
all five trajectories.
The new position of Glu27 in the average structures (Figure 4.5) shows
some differences:
• E27 is bent downwards (i.e. occupies the stable wt closed position) in
E27prot1 and has a transient interaction with Ser137 (see Figure 4.7),
while in the Q-mutants, the Ser137/Q27 interaction is more consistent
and stable.
• The heme cofactor displays very similar positions between the prot1 and
Q2 structures in terms of rotation and plane slanting, while prot2 is simi-
lar in terms of rotation but has a slanting that is similar to Q1’s which, in
turn, displays a peculiar rotation that is responsible for the difference in
RMSD in Figure 4.3. This effect on the heme’s position, which is probably
due to a different tension on the His60-Fe-CO axis at least judging from
His60 sidechain’s orientation (Figure 4.8) might be a sign of a conforma-
tional variability partially explaining the heterogeneous character of the
experimental data.
• In spite of such displacement, the ligand cage provided by hydrophobic
123-125-132-135 residues is preserved (Figure 4.6-b).
As stated above, it is especially the heme RMSD plot (Figure 4.3) that marks
a difference in the structures between the E27Q1 mutant on one side and the
rest on the other.
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Figure 4.4: RMSD (black: protein complete backbone, red: backbone without
the N-terminus LPGE-, green: backbone without the N-terminus LPGE- and the
AB and GH loops) against their respective energy-minimized average structures
after 150 ns. Above: E27prot1/2 (left/right). Centre: E27Q1/2 (left/right).
Below: E27V. (Grace)
This division, though, is not absolute, also as observed above: e.g. the cross-
RMSD values (Table 4.2) for the average structures indicate that Q1 and Q2 are
anyway structurally more similar between themselves than the two protonated
forms between themselves.
The new position of Glx27 is compatible with a H-bond between one of
the sidechain oxygen atoms (even the one hosting the proton, or the only sur-
viving the amidation to Gln) and the hydroxyl of Ser137. The other oxygen
atom or the sidechain aminic nitrogen in Gln, can form bridges with the back-
bone around residues 41-43. On the contrary, Val27’s sidechain cannot obvi-
ously form H-bonds or salt bridges with neighbouring residues and apparently
chooses a slanted, least-clash orientation between Ser137 and the heme. The
distances are shown in Figure 4.7.
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(a) (b)
Figure 4.5: Glx27’s position relative to the heme in the energy-minimized av-
erage structures in E27prot1 (black), E27prot2 (red), E27Q1 (green), E27Q2
(blue) and E27V (magenta) upon backbone alignment. Ser137 and Phe43 (a)
/ Phe41 (b) are shown. (VMD)
As can be seen, all energy-minimized average structures (Figure 4.5) have
Glx27 stretched inside the proximal cavity, except E27prot1. All the same, in-
specting the final structures and checking the distance plot in Figure 4.7, the
bond with Ser137 seems to be much less permanent than the average struc-
tures lead to imagine, and eventually it is only the E27Q1 structure, with its
otherwise peculiar structure, the one where no breaking of such bond is re-
ported, while all others (E27V excluded for obvious reasons) experience, for
shorter or longer times, some return to the old original form with interactions
with Thr168 and Tyr175.
His60’s position
Another interesting element is the position of His60. Besides its stretching in
the mutants, the imidazole ring exhibits different positions along the trajecto-
ries, especially in Q1, as visible in the energy-minimized average structures in
Figure 4.8.
Plotting the distributions of the dihedrals between planes CA-CB-CG and
CB-CG-CD2 of His60 (Figure 4.9), some interesting features include:
• E27prot1/2 and E27Q2 have very similar profiles with a primary (around
190◦) peak and a secondary one (around 120◦)
• E27Q1 has a peculiar profile, with the primary peak shifted to around
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(a) (b)
Figure 4.6: (a) Heme’s position relative to the heme in the energy-minimized
average structures in E27prot1 (black), E27prot2 (red), E27Q1 (green), E27Q2
(blue) and E27V (magenta) upon backbone alignment. (b) Hydrophobic cage
and CO ligand in the energy-minimized average structures (same colour cod-
ing). (VMD)
240◦and a much lower secondary peak similar to the others’
• E27V has a profile similar to the E27Q1 one, with a much more promi-
nent secondary peak shifted at about 150◦.
The data collected so far can be then summarized as follows:
• the general three-dimensional fold of the protein is not affected by the
mutations/variations
• there are local effects, concerning the longest loops but also and more
importantly the heme cavity, where the heme itself and His60, besides all
the residues directly interacting with residue 27, seem to feel the influ-
ence of the mutation/variation
• the full extent of the influence over the heme, in particular, and on the Fe-
ligand bond is not attainable through classical methods; these methods,
though, are capable of highlighting a definitely different stress that these
mutations/variations cause to other elements of the protein fold, e.g. to
the β-barrel core, and to the histidine-cofactor-ligand subsystem.
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Figure 4.7: Distance between one of the sidechain oxygen atoms of Glx27 and
Ser137:HG1 (left), and between the other sidechain oxy/nitrogen atom and
the backbone in residue Phe43/41 (right). (Grace)
back tunnel cagea-to-back cagea-to-front cagea-to-top
wtc s1 80% <10% 28% 50%
wtc s2 34% <10% 26% 55%
E27prot1 46% <10% 23% 31%
E27prot2 47% 10% 27% 24%
E27Q1 25% <10% 13% <10%
E27Q2 41% 13% 39% 53%
E27V 29% <10% 41% 59%
wto 27% <10% 100% 0%
Table 4.3: MDpocket frequencies for tunnels. a For “cage” the hydrophobic
cage is meant, which is completely disrupted by Asp32 deprotonation’s effects
in wto; in this case the proximity of the CO ligand is considered. See Figure
4.10.
Fpocket and ILS
In Table 4.3 the frequencies of tunnels are specified for all the MDpocket runs.
For the mutants, the sampled trajectory windows are those used to calculate
the average structures.
The other structures follow considerations exposed in previous reports (see
4.3.2). For completeness, they are listed below.
wtc s1: 180-190 ns
wtc s2: 220-230 ns
wto: 280-290 ns
The results allow us to disclose a few trends:
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Figure 4.8: Position of His60 (upon heme alignment) in E27prot1 (black),
E27prot2 (red), E27Q1 (green), E27Q2 (blue) and E27V (magenta) in the
energy-minimized average structures. (VMD)
a) access to the back tunnel seems easier in the closed form of wtNP7 than in
the E27Q mutant. Thus, in the former, depending on the specific window,
the access can be as large as 80%, whereas in the E27Q mutant is found to
range from 25% to 41%.
b) the exit to the bulk solvent though the cage-to-top pathway is similar in the
wtNP7 and in the E27Q mutant.
These trends suggest that the ligand, upon flash photolysis, could likely
rebind from regions proximal to the the distal cavity (i.e. site 1) and from
more distant regions (i.e., site 3), thus explaining the two kinetic phases in
the geminate rebinding. However, since the access to site 3 seems to be more
feasible for wt Np7, the ligand should be retained more effectively in the wt
protein, thus leading to a larger fraction of geminate rebinding, as found in the
experimental assays.
ILS runs on the considered trajectory segments offer the values in Tables
4.4 and 4.5, in terms of appearance of docking sites 1a, 1b, 2, 3 (Figure 4.11)
and others. An additional 1c (Figure 4.11) and a 4th docking sites (Figure
4.12) are defined in the distal pocket (columns “1c” and “4”). “BT” (Figure
4.12) stands for “back tunnel” as defined in Table 4.3; “SED” (Figure 4.12)
and “SEA” (Figure 4.13) identify the “side exposure”, meaning the ligand is
almost touched by the ILS isocontour of an external intrusion from side/top
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Figure 4.9: His60:CA-CB-CG-CD2 dihedral angle plot. Left: angle distribution.
Right: time-vs-angle. (Qtiplot)
1a 1b 1c 2 3 4
wtc s1 -3.9 +2.4 +14 -5.8 -4.7 +8.0
wtc s2 -1.9 +3.0 +14 -4.2 -5.9 +7.1
E27prot1 -4.0 -2.2 +3.1 +1.9 -5.3 +6.7
E27prot2 -4.5 -1.3 -0.3 -2.6 -6.5 +1.7
E27Q1 -2.8 +0.9 12 -3.5 -5.4 +3.1
E27Q2 -5.2 -1.9 - -0.1 -4.9 +0.9
E27V -0.3 -1.9 +1.6 -0.1 -5.9 +0.7
wto -6.4 -1.8 -3.2 -1.0 -5.6 +0.3
Table 4.4: ILS isovalues for the docking sites of different structures.
behind the D-propionate’s side and behind the A-propionate’s side respectively;
“CTB” (Figure 4.13) stands for “cage to back” as already seen in Table 4.3;
“BTS” (Figure 4.14) means a direct connection between the back tunnel and
the side (behind the D-propionate’s side) and finally “BTF” (Figure 4.14) is a
direct connection between the back tunnel and the barrel’s mouth through the
proximal pocket or on the heme’s rim at the A- propionate’s side.
One point is important enough to be underlined here. In the “open” struc-
ture (wto), once the back tunnel is connected (the bottleneck is between any of
the sites labelled as 1 and site 2), it is automatically connected to the cage and
to the side, while at lower energy isovalues, sites 2-3 form one single cavity,
and the distal cage, is connected to the sites 1 and to the side (next to the D
propionate).
Taken together, the ILS and Fpocket data about cavities and tunnels do not
allow to point out significant qualitative differences in the cavity/tunnel system
of the mutants, once taken into account the different position of the heme
that characterizes the E27Q1 structure, which influences some of the energetic
barriers, but which also seems only one of the possible conformational variants
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Figure 4.10: Tunnels in NP7 mutants. Supporting image: wtc s1; back tunnel
and cage-to-top images caught at iso 50% frequency, cage-to-front at iso 28%
frequency (see Table 4.3). (VMD)
of a configuration-shifting structure.
One important remark, though, is possible by noticing in Table 4.4 that the
energetic minima 1a and 2 for E27V are among the highest, while minimum 4 it
is one of the lowest. This agrees with the observations in 3.3.5 about the cavity
system of NP4 (which, like all other NPs, has a valine instead of NP7’s Glu27),
and shows the importance of Glu27’s steric influence on the cavity system.
The results in Table 4.5 show that the most favourable pocket is site 3,
which appears at an energy value almost constant for all proteins. Thus, if a
photolyzed ligand gets site 3, it will show a slower geminate rebinding due to
the energetic stability of the pocket in the rear of the tunnel. It is also worth
noting that transition from site 1 to site 2 is favourable in the wt protein, but
that the opposite trend is found for the E27Q mutant (note also the larger
barrier for motion through the back tunnel in Table 4.4 for the E27Q mutant).
This suggests that a photolyzed ligand will have larger tendency to occupy site
3 in the wt protein than in the E27Q mutant, thus explaining the larger fraction
of geminate rebinding in the former.
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BT SED SEA CTB BTS BTF
wtc s1 +2.6 +10a +19 +60 +60 +29
wtc s2 +5.3 +5.4a +18 +50 +53 +30
E27prot1 +5.2 +12 +35 +59 +31 +60
E27prot2 -0.1 +3.6 +10 +27 +18 +65
E27Q1 +3.2 +11 +30 +34 +45 +24
E27Q2 +9.1 +0.4 +20 +33 +24 +55
E27V +8.2 +4.0a +19 +32 +36 +53
wto +10 - +11 +10 +10 +50
Table 4.5: ILS isovalues for the tunnels of different structures. a “Top” con-
nected at lower isovalues. For the tunnels definitions, see 4.3.2.
Figure 4.11: Cavities in the interior of the protein. (see Table 4.4). (VMD)
4.3.3 APBS results and how they can be interpreted
Due to the presence of many positively charged residues in the far end (with
respect to the heme pocket) of the barrel of NP7, its isoelectric point is much
higher than that of all other NPs (see Table 1.2). Globally then, for NP7 the
creation of a negative charge by means of the acidic dissociation of a ionizable
residue is favoured, and the pKa for Asp32 in NP7 should be expected to be
lower than the pKa value of Asp30 in NP4. The E27Q mutation amplifies this
reduction, as it increases the charge imbalance and makes the dissociation of
Asp32 even more favourable: therefore the E27Q pKa for Asp32 is expected to
be even lower than in wtNP7.
The results of the APBS run on wt NP7c and NP7o, NP7(E27p), NP7(E27Q)
and NP7(E27V) are summarized in Table 4.6.
From these figures, a prediction for the experimental pH of conformational
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Figure 4.12: Back Tunnel (BT) and Side Exposure by D-propionate (SED), with
cavity 4. (see Table 4.4). (VMD)
change for the E27Q mutant can be done in a rough way as in Table 4.7. The
result is of course at least partially arbitrary, lacking the methodologically val-
idating procedure (CpHMD) followed for NP4 in [67], and a difference in a
decimal can lead to important differences in the closed:open ratio for any struc-
ture. All the same, the trend is rather reliable and worth noticing.
First of all, the data about NP4 can fit the experimental observation in [66]
of a heterogeneous behaviour of NP4 at pH 7.5. The 1:10 and 10:1 ratios are
mirrorlike because the apparent pKa is 6.3, right in the middle between the ex-
perimental pH values (the experimental apparent pKa is 6.4, which also agrees
with the estimated pKa for closed and open forms from CpHMD calculations:
8.5 and 4.3, respectively). Assuming that the open form, being more flexible,
can assume a variety of actual configurations, with water molecules able to in-
vade the heme cavity and therefore with different competition and evacuation
patterns on ligand rebinding, the above mentioned heterogeneous behaviour
can be justified.
The estimates in Table 4.7 indicate that in the wt case at pH = 5.5 there is
an almost even open-closed mixture. Then, if the ligand rebinds to the closed
form of the protein, where the cage must be preformed and the water molecules
that fill the cavity in the open species should have been already released, at pH
5.5 CO should exhibit a faster bimolecular rebinding than at pH 7.5, where the
open form will be the predominant species. In contrast, since the apparent pKa
of the E27Q mutant is 4.9, the fraction of open species must be predominat at
the two pHs, thus explaining the similar profiles obtained for the mutant.
In any case, the finding that the pKa appears to be much lower for E27Q
explains in a convincing way the mutant’s lack of sensitivity to pH and the fact
that its bimolecular rebinding signals are much more similar to wt’s at neutral
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Figure 4.13: Side Exposure by A-propionate (SEA) and Cage-To-Back (CTB).
(see Table 4.4). (VMD)
Figure 4.14: Back-To-Front (BTF) and Back-To-Side connections (BTS). (see
Table 4.4). (VMD)
pH.
4.4 Conclusions
The key role of Glu27 in NP7, and therefore of the unique NP family-wise
mutation Val→Glu seems to get a clearer contour.
As the steric presence of Glu27 is to be held responsible for the particular
heme orientation selectivity that NP7 displays, now to its charge the function-
ing of Asp32’s pH switch between the two physiologically relevant pH values
can be ascribed, at least partially.
In fact, in comparison with other members of the NP family, the presence of
a higher number of positively charged Lysine residues in the back of the protein
would considerably lower the pKas of all negatively charged residues, includ-
ing Asp32’s, and this would lead in turn to a shift of the pH window where
the protein undergoes a conformational change between the closed and open
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structure traj. avg. struct. avg.
wtc1 +3.0±0.3
+2.9±0.4
wtc2 +2.7±0.4
E27p1 +2.9±0.3
+2.7±0.4
E27p2 +2.4±0.3
E27V +2.3±0.3
E27Q1 +2.0±0.3
+1.9±0.5
E27Q2 +1.7±0.6
wto1 +0.0±0.4
+0.0±0.3
wto2 +0.1±0.3
Table 4.6: Asp32 pKa shifts. (APBS)
structure c/o pKa apparent pKa c:o ratio pH 7.5 c:o ratio pH 5.5
NP4 8.9/4.0 6.3 1:10 10:1
wtNP7 6.9/4.0 5.4 1:125 1:1.25
NP7(E27p) 6.7/4.0 5.3 1:167 1:1.67
NP7(E27V) 6.3/4.0 5.1 1:250 1:2.5
NP7(E27Q) 5.9/4.0 4.9 1:400 1:4
Table 4.7: Projection of apparent pKas for NP7.
forms, or, equivalently, to a less efficient pH switch mechanism between insect’s
saliva and victim’s blood due to an incomplete conformational transformation.
The Val→Glu mutation, introducing an extra negative charge in NP7, only
partially counterbalances the charge difference, but apparently through its in-
teraction network is able to modify the electrostatics in the heme’s environment
in such a way as to keep Asp32’s acidity constant high enough as to allow the
pH switch to work between the two physiological pH values.
This mutation also seems to cause a modification in the structure of tunnels.
The presence of a better defined tunnel in wt may explain the larger amplitude
of the second geminate phase (ca. 0.5× 10−9 s), whereas in E27Q this phase
has approximately the same amplitude as the faster one (ca. 0.5× 10−10 s). In
wtNP7, the more accessible secondary docking site(s) may then be held respon-
sible for the larger amplitude of the ca. 0.5 s× 10−9 s decay. The computational
results then offer a good agreement with the experimentally observed results
for the geminate rebinding phase. The difference in the extent and the rates be-
tween pH 7.5 and 5.5 is much larger in wtNP7 than in NP7(E27Q): the data for
the mutant are both more similar to those at neutral pH for the wt, suggesting
that the effect of the imposed pH change is weaker for the former. For the wt
protein the rates and the amplitudes of the exponential decays become larger
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when pH is lowered, and the corresponding increase (in rates and amplitudes)
observed in E27Q is much less pronounced.
Besides adding experimental data about the NP7(E27Q) and NP7(E27V)
mutants in comparison with wtNP7, further computational studies must be de-
veloped in order to better understand whether Glu27’s role is accompanied
by other unique residues’ concurring action, and in order to refine the model,
possibly using the same CpHMD methods already cited above, thus seeking a
better agreement between the model itself and the experimental data.
Chapter 5
NP7 and membranes
5.1 The questions addressed
NP7 is known since 2003 [30, 32] and almost immediately its feature of bind-
ing to anionic phospholipidic membranes was recognised [33].
The connection between the family-unique polybasic sequence found in
NP7 and the possible adsorption to negatively charged lipidic layers was ad-
vanced in 2004 [31].
Deeper insight about the membrane-binding properties was offered by [57,
58], and, more recently, by [70].
Suggestions contained in [70] and personal communications with the au-
thors led to focus the attention on residues Arg141, Ala145, Pro147 and Ala154
as those among the NMR-labelled ones giving different signals between the in-
solution and membrane-bound situations.
In the light of the results shown in the previous two chapters of MD studies
of NP7 in solution, and especially in the light of the existence of an axial tunnel
connecting the distal cavity to the “back” of the protein, affected by the pH con-
formational switch and with possible implications on the NO load-and-release
mechanism, a computational study was performed with the aim to find detailed
clues as to how the membrane binding happens, what its structural impact is,
and what signs of its features can be detected experimentally.
5.2 Methods
5.2.1 The force field
The choice of a force field is obviously crucial for the quality of the results. The
recent publication of the new, experimentally validated CHARMM36 parame-
ters for lipids [112], oriented the choice of the force field for representing NP7
interacting with a model membrane.
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Figure 5.1: Carmen, the system as it looked before MD runs (water molecules
are not shown). (VMD)
5.2.2 Building the systems
MD simulations were run on two different systems, composed each of a phos-
pholipidic bilayer and a NP7 molecule, in carboxy closed and open forms.
The two systems, (approximately 110k atoms each) were named “Carmen”
(“Chiusa” - closed NP7 + membrane), shown in Figure 5.1, and “Azucena”
(“Aperta” - open NP7 + membrane).
The two systems were built using the same model membrane and adding
to it the two protein variants.
The protein
For the proteic part, two snapshots were chosen from the stability regions of the
trajectories described in Chapter 3. The snapshots were stripped of all water
molecules and counterions and then merged (VMD script) with the membrane
part of the system.
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Figure 5.2: Dilauroyl-L-α-phosphatidylcholine (DLPC - left) and dilauroyl-L-α-
phosphatidyl-L-serine (DLPS - right). (Source: NCBI Pubchem)
The membrane
The membrane was built using the Membrane Builder [113, 114] input gener-
ator on CHARMM-GUI [115].
For the membrane composition, according to [57], was chosen as a 3:1
mix of L-α-phosphatidylcholine (PC) and L-α-phosphatidyl-L-serine (PS) for the
polar heads, while for the lipidic tails two lauroyl chains (DL) were chosen1.
The two phospholipidic molecules (DLPC, DLPS), are shown in Figure 5.2.
A square 85Å×85 Å bilayer was built using 96:32 molecules of DLPC:DLPS
per side. This was enclosed in a 85Å×85Å×140 Å tetragonal water box, with
the bilayer stretching in the z = 0 plane and dividing the water box in two non-
communicating volumes, one “above” and one “below” the bilayer (positive
and negative z coordinates, respectively). In terms of the z dimensions, the
bilayer’s thickness, head to head, measured about 20 Å, leaving two volumes
about 60Å deep on both sides for water and ions (and for the insertion of the
protein)2.
1Lauroyl tails were chosen because their chains, shorter than those from other more physio-
logically relevant fatty acids, allow a smaller system in terms of number of atoms, and therefore
represent, with suitable adjustments, a fair compromise between computational complexity and
model realism. Just as an example, the use of palmitoyls instead of lauroyls on the same mem-
brane system would have added over 6k fully interacting atoms to the atom count. The drawback
of a less massive membrane is anyway overcome by positional constraints on the lipidic tails im-
posed to prevent the membrane from being displaced by the interaction with the protein. An
important plus in the choice of DLPC was the fact that this particular lipid is one of the six used
in [112] to validate the CHARMM36 force field, and the computational performance of a model
of DLPC based on such force field parameters is therefore to be considered of high quality.
2This thickness was chosen so that the protein could fit conveniently in the top water volume
without being too close to the nearest surface and allowing for several layers of water molecules
in between, and at the same time being far enough from the negatively charged bottom layer of
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value all s1 s2 s3 s4 s5 s6
cgema (×1000) 10
timesteps (×1000) 25 25 25 100 100 100
timestep value (fs) 1 1 1 2 2 2
Langevinb temp on
Langevinb damping 10
Langevinb H no
Langevinb piston (LP) off off on on on on
LPb period 50 50 50 50
LPb decay 25 25 25 25
Table 5.1: NAMD settings for membrane equilibration. a Conjugate gradient
energy minimization steps. b For Langevin dynamics, see reference settings in
Table A.2.
At this point, the atom count read 26688 atoms for the bilayer, about 87300
atoms belonging to TIP3 water molecules, 107 K+ and 43 Cl− counterions to
balance the overall negative charge of the DLPS molecules (each carrying a -1
charge), compatible with a 0.15 M KCl concentration.
The CHARMM-GUI online server was used to assemble the bilayer. Its out-
put includes the NAMD input files for a 6-step equilibration phase and the pro-
totype input file for production dynamics. Therefore, unlike all other protein
simulations mentioned so far, for the system comprising the membrane alone
the settings were not based on those shown in Appendix A, but as in Table 5.1.
The membrane-only system therefore underwent an initial 10000 steps en-
ergy minimization procedure and then an equilibration phase simulating an
overall period of 675 ps. During this equilibration steps collective variables
(colvars) were set and used in order to constrain and monitor the membrane
thickness and area, while other extra constraints were applied on improper
dihedrals in order to maintain the planarity of the membrane.
This preparatory phase was followed by a full production MD run of the
membrane alone spanning 50 ns and set as the last equilibration step.
During these steps the area-per-lipid and the layer thickness were con-
stantly monitored and this showed that the system was able to retain the sta-
bility gained during the equilibration process, as can be seen in Figures 5.3 and
5.4.
Only at this point were the membrane and the two protein structures as-
sembled in two separate systems.
the nearest periodic image of the membrane so that it would not “feel” its influence.
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Figure 5.3: Area-per-lipid (top and bottom layers share the same values) for
membrane in free MD. (Grace)
5.2.3 Assembling the systems
The Carmen and Azucena systems were assembled by placing the protein struc-
ture (derived, it is worth remembering, from snapshots extracted from stable
parts of trajectories of the same proteins in solution, i.e. with the protein al-
ready well equilibrated and in reliable simulation conditions) into the mem-
brane’s large water box.
In order to do so, a specific VMD script allows to overlap the two pdb files,
including the protein in the water box and deleting from it all water molecules
and ions that happen to be in the position where the protein is set.
The protein was set on the “upper” side, that is where z > 0, at a minimum
distance from the polar heads of the membrane of 10 Å, the β-barrel axis per-
pendicular to the membrane’s surface and the “back” of the barrel closest to the
surface.
Placing the protein at such distance, i.e. where the electrostatic interac-
tions between the positively charged lysines of the “back” of the protein and
the negatively charged PS heads are weak yet present, allows to set a Steered
Molecular Dynamics run with a constant velocity approach of the protein to
the molecule that permits a gradual evacuation of water molecules from in be-
tween, a “soft landing” of the protein onto the membrane with a progressive
engagement of all the lysines that can be involved in the process.
The reason why the “back” of the barrel was set facing the membrane, as
opposed to its “mouth” or other parts, is that it is exactly in the “back” area that
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Figure 5.4: Layer thickness (averaged over the two layers and over time) for
membrane in free MD. (Grace)
the polybasic sequence that stands out as unique in the NP family is located.
The basic assumption is that NP7’s peculiar behaviour with anionic membranes
is directly related to the peculiar structural feature of an accumulation of pos-
itive charge at the rear end of the β-barrel, and that this direct relation is
interpretable as an electrostatic interaction with the negative charges in the
membrane.
The two systems so obtained underwent the usual energy minimization
procedure described in A.1.2. The equilibration phase for the two systems
was longer and more articulated than in Table A.1. Its outlines are contained
in Table 5.2. After these four equilibration steps, amounting to a 500 ps the
systems were deemed ready for the next passage, i.e. SMD, in order to slowly
bring the protein closer to the membrane and cause the interaction to gradually
activate.
5.2.4 Steered Molecular Dynamics
Steered Molecular Dynamics (SMD) is a MD variant where external forces are
introduced in order to drive molecules or components in particular movements
of interest. Whereas this technique is often combined with trajectory sampling
(see [116]), in the present case its choice was based on the considerations that
a free MD would potentially lead either to a long wait before the protein starts
moving towards the membrane, a waiting during which the protein itself might
rotate and present itself with orientation that would not favour the interaction,
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value all s1 s2 s3 s4
temperature (K) 100
50→300 300 300 300
Langevin temperature control no no no yes
Langevin pressure control no no no yes
steps (×1000) 25 12.5 12.5 200
timestep (fs) 2
restraintsa yes
force const.a (kcal mol−1 Å−2) 25 12.5 5 5
Table 5.2: NAMD equilibration settings for Carmen and Azucena. aElastic re-
straining force applied to the lipidic tails, with elastic constant given in the
“force const.” row. See reference settings in Table A.2.
or to an immediate free fall towards the membrane, which might prove dis-
astrous for the membrane itself because of the unmitigated impact. A driving
force applied to the protein’s centre-of-mass could avoid both problems.
NAMD allows to do this in different ways. In the present case, a constant
velocity was needed in order to start the protein approach to the membrane at
first and then to slow down its electrostatics-driven descent on it without harsh
collisions that might disrupt the membrane (or, something that would be a bit
less likely because of the rigidity of the protein’s β-barrel, the protein fold).
The result was the application of a variable force of suitable direction to the
protein’s centre-of-mass.
Together with SMD, positional constraints were applied in certain simula-
tion steps to the lipidic tails at the centre of the membrane in order to prevent
the membrane itself from moving from its z-central position because of the
attractive interaction or the collision with the protein.
A constant velocity along a vector that would bring the protein more or less
to the centre of the square bilayer once in proximity of its surface (during equi-
libration the protein was free to drift in the solvent) and whose z-component
would amount to 0.1Å ns−1 was then set for the SMD run. Such a force was
applied as a harmonic force with an elastic constant of 5.0 kcalmol−1 Å−2 on
the COM according to its distance from its kinematically projected position
along the direction vector with the given velocity magnitude after the simula-
tion time.
The SMD simulation was constantly monitored through the output values of
force components and COM position that allowed to detect when the protein
had reached the minimum distance and started bouncing on the membrane,
i.e. the moment to switch off the steering force. The switch-off was performed
by setting the force constant to zero instead of switching the SMD engine off
entirely, in order to keep NAMD reporting about COM’s position (see Figure 5.5
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Figure 5.5: SMD monitoring plot for Carmen (left) and Azucena (right) after
300 ns. Above: x and y COM coordinates. Below: z COM coordinate. Applied
force mainly along the z axis, off after 50 ns for Carmen, 84 ns for Azucena.
(Qtiplot)
as an example).
For Carmen the switch-off could be performed after 50 ns for the steering
force and after 60 ns for the lipidic tail constraints. Azucena found more dif-
ficulties in settling on the surface of the membrane, and it took 84 ns before
the steering force could be switched off, and 110 ns before the lipidic tail con-
straints could be removed.
5.2.5 Free ligand MD
Free ligand MD simulations were run on Carmen and Azucena, as reported in
3.2.2 and 3.3.4. The differences with the ones in Chapter 3 are the following:
• only initial positions A and B (see Table 3.5 and Figure 3.5), i.e. sites 3
and 1 respectively, were used, as the connectivity of the axial tunnel was
the issue to be analysed;
• a larger sampling (10 runs instead of 5) was chosen for the same times-
pan of 20 ns each;
• the initial structures were the final snapshots (after 400 ns) of the Azu-
cena and Carmen trajectories.
5.3 Results and discussion
5.3.1 After the SMD runs
The production MD phase followed the preparatory SMD runs. The systems
obtained at the end of the preliminary phase were considered satisfactory under
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Figure 5.6: Carmen during MD. In blue: Lysines. In grey: PC. In red: PS.
(VMD)
several aspects.
First of all, the constant velocity SMD process resulted in the application
of a braking force when the proteins accelerated under the coulombic force
beyond the target value. This is witnessed by the lower plots in Figure 5.5.
Visual inspection shows that this phase had no disruptive or deformation effects
on the membranes, thanks to the positional constraints applied to the lipidic
tails which kept the membrane in position. Eventually, after the release of
such constraints in ordinary MD, the kinetic energy added to the system in the
SMD phase led to a definite displacement of the membrane towards z < 0, as
can be seen in Figure 5.7, while the vicinity of the protein bent the bilayer, in
part by colliding and in part for electrostatic attractions between parts of the
membrane and of the protein not directly in contact.
Secondly, when the lipidic tail constraint was released, a reorganization of
the DLPS molecules in the upper layer of the membrane started, which resulted
in a higher concentration of negative charges around the protein contact area,
as shown in Figure 5.8. This is worth mentioning: it is an expected effect of the
presence of a concentration of positive charge near the surface of an anionic
membrane. Of course the light mass of the chosen phospholipids influences this
effect, probably mainly in terms of its characteristic times. On the other hand
might be a realistic effect with a possible physiological relevance, since the
negative charges may have an important role in the docking of other proteins
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Figure 5.7: Left: side section of the membrane bilayer at the end of the SMD
phase for Carmen (red) and Azucena (blue), and Carmen after 192ns, during
the ordinary MD phase. Right: side section of the membrane bilayer of Carmen
after 192 ns with NP7; the membrane is slightly bent under the protein. (VMD)
related to the coagulation process, and therefore their concentration around
NP7 on the activated platelet’s surface might be a disturbing factor in that same
coagulation process.
In the third place, the docking approach took place in a significantly longer
time for Azucena than for Carmen. The reason for this can be partly pinned
in large measure on the conformational variability of the long loops that char-
acterizes the open form of NP7 and that is likely to influence the more or less
orderly way the protein approaches the membrane. At the SMD switch-off,
the protein in Azucena was rebounding on the membrane with larger ampli-
tudes than in Carmen. This is the main reason why at the same instant Car-
men presented a protein maturely docked to the membrane, while Azucena
took a longer adjustment time before it could be recognised as being that ma-
turely docked. Despite all this, though, the protein’s positioning, the involved
residues, the position of the secondary structures, mainly the α-helix, most in-
volved in the interaction, are the same in the two systems, as can be seen in
Figure 5.9.
5.3.2 Comparison between Carmen/Azucena and wtc/o
After reaching a stable distance between the membrane and the protein back
(see Figure 5.6), with the involvement of all available Lysines (12, 13, 19, 116,
149, 152, 153, 157) the production MD run was extended to 400 ns for both
Carmen and Azucena.
Comparing the final snapshots (Figure 5.10) and calculating the RMSD for
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Figure 5.8: Distribution of DLPS on the upper layer in absence (membrane
before assembling with protein) and in presence of NP7 (Carmen, after 400ns).
In grey: PC. In red: PS. In yellow: NP7. In blue: Lysines. (VMD)
different selections (Table 5.3) the following remarks can be done:
• the β-barrel is very stable, especially in the open structures;
• a similarity between closed and open structures is apparent;
• the displacement of the heme in the open form is similar but there are
differences in the closed structures (see below, Figure 5.17);
• the segment composed by residues 141-154 (see Section 5.1) is confor-
mationally insensitive, its RMSD remains under the average value in ev-
ery case and in the cross open-closed RMSD it is even lower than the
β-barrel’s.
5.3.3 Comparison with experimental data
As it was mentioned above (Section 5.1), attention was devoted to residues
Arg141, Ala145, Pro147 and Ala154, residues that were NMR-labelled and
gave different signals between the in-solution and membrane-bound situations.
For the last three residues, this experimental fact is easily explained in terms
of the interaction model imagined, as they all belong to the loop preceding, and
to the α-helix singled out as the protein’s part mainly involved in the protein-
membrane interaction, and would therefore be held compressed between the
protein core and the membrane as the interaction takes place, while they would
enjoy a relatively larger freedom of movement when the protein is not inter-
acting with membranes.
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Figure 5.9: Carmen (left) and Azucena (right) docking to the membrane at the
end of the SMD phase. (VMD)
In Table 5.4 the differences between the RMSD of these residues and the
average protein RMSD are reported. All RMSD are calculated against a single
reference structure (final snapshot of wtc at 300ns), counting all heavy atoms
(i.e. including sidechains, which is relevant especially for Arg141), using a
100 ns long sampling time (i.e. the last 100ns of the four trajectories). The
difference between the residue value and the overall average gives thus a mea-
sure of the residue displacement with respect to the whole protein. For these
residues a difference between the wtc/o and the Carmen/Azucena values is
expected.
A first remark is that in all cases these residues have a lower displacement
than the average of the protein (the values are all below zero). Secondly, the
membrane-bound values do not always show a lower mobility than the ones in
solution, and this suggests that the different behaviour is not simply due to a
compression between the membrane and the protein core, as proposed above.
Besides, for the closed structures, data in Table 5.4 show significant differ-
ences in Ala145, Pro147 and Ala154, while for the open structures the differ-
ences only involve Pro147 and Ala154.
Information about the mobility of this segment of the protein is shown in
Figure 5.11, representing the backbone RMSF of the closed and open trajecto-
ries both in interaction with the membrane and in solution. While in the closed
forms there is a definite difference concerning the single Asn144 and Pro147
residues, in the open structures the whole α-helix, starting with Pro147, dis-
plays an overall different mobility, which is reflected in a reduced fluctuation.
Generally speaking for Ala145, Pro147 and Ala154, therefore, the model
might be in partial agreement with the NMR data, even though the magnitude
of the geometrical changes is only moderate.
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wtc Azucena wto
Carmen 1.996 3.151 3.260
1.632 1.274 1.120
1.524 2.260 2.418
wtc 2.858 2.896
1.537 1.537
1.964 2.013
Azucena 1.739
1.055
0.680
Table 5.3: Cross-structure RMSD (in Å) for membrane-bound and in-solution
structures, final snapshots. In black: full backbone atoms. In green: residues
141-154 backbone atoms. In red: β-barrel backbone atoms. (VMD-RMSDTT)
Carmen wtc Azucena wto
Arg141 -1.271 -1.169 -2.360 -2.331
Ala145 -0.297 -0.918 -1.287 -1.229
Pro147 -0.896 -1.218 -2.406 -1.833
Ala154 -1.638 -1.296 -2.031 -2.335
Table 5.4: Difference (in Å) between the heavy-atom RMSD of single NMR-
relevant residues (vs. final wtc structure, averaged over the last 100 ns) and
average heavy-atom RMSD (same reference, same sampling time).
Arg141, on the contrary, does not show the expected differences.
Direct inspection shows that in all cases, Arg141’s sidechain is trapped in a
network of interactions with Lys19 and Lys116, with Ser22 and Thr24 (Figure
5.12), and this stabilizes its sidechain’s position throughout all the trajectories.
This explains why the RMSD data show no real difference between in-solution
and membrane-bound NP7 as far as Arg141 is concerned.
A suggestion from the NMR data concerned a possible torsion of the Cβ -
Cγ or Cγ-Cδ bonds upon liposome binding, which would be instrumentally
detectable. While the latter bond does not reveal any particular difference
between the in-solution and the membrane-bound structures, the distribution
plot (Figure 5.13) of the dihedral angle CA-CB-CG-CD, i.e. the angle between
the two planes defined by carbon atoms Cα, Cβ and Cγ on one side, and Cβ ,
Cγ and Cδ on the other, shows a definite difference between Carmen and wtc,
and a very similar pattern between wto and Azucena; for the open structures
there is also a trend that is inverted with respect to the closed structures (i.e.:
in Carmen there is a strong 180◦ peak not appearing in wtc; in wto there is a
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Figure 5.10: Backbone superposition of Carmen (mauve)/wtc (red) and Azu-
cena (cyan) /wto (blue). (VMD)
Figure 5.11: Comparison of the RMSF of the back α-helix region. Left: Carmen
and wtc. Right: Azucena and wto. (VMD)
weak 180◦ peak not appearing in Azucena).
Naturally this different orientation of the sidechain stem, even if not mod-
ifying the mobility of the sidechain itself trapped in multiple hydrogen bonds,
can be originated by small structural rearrangements due to the vicinity of
the membrane, and including the already mentioned different position of the
heme, or changes in the orientation of the hydrogen-bonding residues Ser22
and Thr24, as can be seen in Figure 5.14.
It is possible that the differences in the NMR signals are due to large re-
arrangement phenomena occurring on longer timescales than those simulated
hereby. It seems likely, though, that the presence of an electrically charged
membrane so near the rear of the protein can cause detectable shifts in the
signals, and that the observed shifts for Arg141 can be explained at least in a
large measure, rather than to the loss of the H-bonds or other drastic geomet-
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Figure 5.12: Arg141 sidechain hydrogen bond network in Carmen. (VMD)
rical changes, as the effects of either of, possibly both, these causes:
1. change in the hydrogen bond pattern keeping the sidechain blocked
2. torsion in the Cβ -Cγ bond due to small rearragement effects.
The NMR data apparently can be justified in the in silico model, and this
speaks in favour of the quality of the model used. The same model can then be
used to try and extend the knowledge of the NP7-membrane system, especially
in what concerns the ligand migration paths.
5.3.4 MDpocket, ILS and free ligand MD
In order to obtain the MDpocket results (Table 5.5), two time windows were
used for both methods and for both Carmen and Azucena structures. For the
MDpocket runs only the protein structure was used, as the membrane does not
have a direct steric influence on the protein interior, while for the ILS calcula-
tions (Tables 5.6 and 5.7) the system included the membrane as electrostatic
potentials are involved in determining the energetic profiles.
The time windows for both Carmen and Azucena structures were the 330-
340ns (s1) and the 370-380 ns (s2) ones.
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Figure 5.13: CA-CB-CG-CD dihedral angle distribution for Arg141 in Car-
men/Azucena and wtc/o. (Qtiplot)
back tunnel cagea-to-back cagea-to-front cagea-to-top
wtc s1 80% <10% 28% 50%
wtc s2 34% <10% 26% 55%
Carmen s1 39% <10% 21% 36%
Carmen s2 44% <10% 53% 39%
wto 27% <10% 100% 0%
Azucena s1 18% <10% 100% 0%
Azucena s2 20% <10% 100% 0%
Table 5.5: MDpocket frequencies for tunnels in Carmen and Azucena. a For
“cage” the hydrophobic cage is meant, which is completely disrupted by Asp32
deprotonation’s effects in wto; in this case the proximity of the CO ligand is
considered. See Figure 4.10.
As can be seen, both methods indicate that the connection between the
heme pocket and the back of the protein via the axial tunnel is affected by the
interaction with membrane.
First, for the open species the connection between sites 1 and 3 seems to be
slightly less effective upon binding to the membrane than in solution. Thus, the
simulation with free NO indicate that the ligand remains in site 3 or is released
to the bulk solvent when it was located in site 1.
Second, in the closed species, the data derived from MDpocket and ILS
calculations suggest similar qualitative trends for the protein in the membrane
and in solution. However, the simulations performed with free NO point out a
distinct behaviour. Thus, whereas in solution there is a passage of the ligand
from site 1 to site 3 (and viceversa), the results for the protein attached to the
membrane indicate that the ligand has a strong preference for moving from site
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Figure 5.14: Arg141 and its neighbours in Carmen and wtc. (VMD)
1 to site 3, while the opposite displacement is not observed.
This seems to indicate that:
• the structural strain that is induced on the protein upon membrane bind-
ing has a consequence of a slight “freezing” of the cavity lining sidechains;
this is visible comparing the mobility of the residues lining the 1, 2 and 3
cavities in Figure 5.16, where the mobility loss is particularly visible for
the residues lining cavities 1 for both open and closed structures, and for
those lining cavity 3 in the closed structures, though in this latter case it
is accompanied with a moderate increase in the fluctuations in site 2;
• the conformation the sidechains are “frozen”into does not allow the high
energetic barriers between inner sites to temporarily drop;
• the energetic barrier between the distal pocket and site 1 is greatly in-
creased because of a deeper and slightly rotated position of the heme
in the barrel in Carmen than in wtc (Figure 5.17) which allows less
space between the pyrrole-I (see Figure 1.3) vinyl and the neighbouring
sidechains.
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1a 1b 1c 2 3 4
wtc s1 -3.9 +2.4 +14 -5.8 -4.7 +8.0
wtc s2 -1.9 +3.0 +14 -4.2 -5.9 +7.1
Carmen s1 -3.9 +0.1 +2.4 -3.2 -3.8 -4.2
Carmen s2 -4.9 +0.7 -1.2 -2.0 -4.8 -4.8
wto -6.4 -1.8 -3.2 -1.0 -5.6 +0.3
Azucena s1 -5.7 -0.5 -4.4 -1.1 -5.9 +0.6
Azucena s2 -4.9 -1.9 -1.7 -1.7 -5.2 +0.0
Table 5.6: ILS isovalues for the docking sites of wtNP7 in solution and
membrane-interacting.
BT SED SEA CTB BTS BTF
wtc s1 +2.6 +10a +19 +60 +60 +29
wtc s2 +5.3 +5.4a +18 +50 +53 +30
Carmen s1 +3.4 +9.8a +3.4 >85 +85 +19
Carmen s2 +3.2 +22a -1.0 >85 +85 +15
wto +10 - +11 +10 +10 +50
Azucena s1 +23 - +14 +23 +23 +44
Azucena s2 +21 - +14 +21 +21 +65
Table 5.7: ILS isovalues for the tunnels of wtNP7 in solution and membrane-
interacting. a “Top” connected at lower isovalues. For the tunnels definitions,
see 4.3.2.
On the other hand, while in Azucena the direct exposure of the heme to
the solvent is already high being similar to that of wto, in Carmen the in-cage
energetic minimum (site 4) is much deeper than in NP7 in solution, and the
SEA (frontal) escape route is significantly favoured.
5.4 Conclusions
Membrane-binding is a unique capability exhibited by NP7 alone among nitro-
phorins.
This study could prove that indeed the Lys higher concentration at the back
of the barrel is related to such capability. Furthermore, it could show the impor-
tant role of the α-helix segment in the protein-membrane interaction process.
Seeing the impact the interaction with the membrane has upon the axial
tunnel, a suggestion can be made about a possible functional distinction of NP7
in the context of the Rp nitrophorins. It is not clear yet how membrane binding
can influence the pH value at which the conformational transition (related,
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Figure 5.15: Free NO distributions for membrane-bound NP7. Top left: open
structure (Azucena), NO starting position site 1 (black) and site 3 (red). Top
right: closed structure (Carmen), NO starting position site 1 (magenta) and
site 3 (orange). Bottom: reference profiles for wto (left) and wtc (right). In all
plots the counts were normalized by the number of planned MD steps, in order
to also visualize the ligand’s residence inside the axial tunnel or its escape. The
plots on wtNP7 summarize the data shown in Figure 3.6. (Qtiplot)
as discussed in Chapter 3, to the protonation state of Asp32, its consequent
interaction with Ile132 and the positioning of loops AB and GH) or the NO
affinity, and whether it may be triggering NO release or not. Nevertheless, in
a membrane-bound NP7 the communication between the heme pocket and the
interior of the protein is made more difficult, while the frontal exchange with
the solvent easier. All this seems to indicate the possibility that, if nitrophorins
are a family of proteins releasing vasodilating NO on different timescales into
the blood vessels during Rp’s meal, NP7 might be the one whose time frame is
the last, i.e. when the immune system has detected the presence of endothelial
damage and activated platelets begin repairing the wound through which the
insect is pumping saliva in and blood out.
In other words, if the picture offered by the present study is correct, and
this can only be determined through deeper and more specific experimental
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Figure 5.16: Comparison of RMSF (Å) values for the open structures (left:
bright colours for wto, dark colours for Azucena) and for the closed structures
(right: bright colours for wtc, dark colours for Carmen). (OpenOffice)
research on membrane-bound NP7, the protein’s function might be to release
NO at the last stage of the meal, to keep a sufficient blood flow even while the
bite is starting to be healed by the victim’s defensive devices. There are other
possible alternative or additional interpretations, such as selective and specific
binding to membrane proteins, or interference with platelet aggregation and
clumping through shielding and concentration of negative charges.
This functionality hypothesis is consistent with the fact that NP7 is only
expressed in nearly-adult or adult insects, i.e. when the feeding needs are
higher and the chances of being detected and hunted by the victim during a
longer meal are also higher. The evolutionary strategy of deploying different
nitrophorins might then be seen as aimed at keeping the NO release constant
during all the time of the meal, in order to increase the blood flow, block the in-
trusion messengers as histamine and the biochemical cascades leading to blood
coagulation and wound repair. In this picture, NP7 might as well be seen as the
last one to release NO: when coagulation has started, and the insect’s meal is
at its end, NP7 allows Rp a dessert.
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Figure 5.17: Comparison between the heme’s position in Carmen (blue) and in
wtc (red). (VMD)
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Appendix A
MD settings with
NAMD/charmm
A.1 A typical setup
Typically, for NP7 in solution, a standard NAMD/charmm [76, 78] steps and
setup for the different pre-production and production dynamics runs are sum-
marized in Tables A.1 and A.2.
A.1.1 Preparation
Given an initial structure for NP7, the preparatory steps before submitting MD
calculations include:
1. parsing the pdb file checking residue names, protonation states for his-
tidines, heme orientation;
2. building the psf structure file; to this end, the AutoPSFbuilder extension
of VMD [90], loading the standard charmm22 topology files, including
also the specific heme and CO topology files [78], specifying the patches
(ASPP if Asp32 is to be protonated, DISU for disulfide bridges, PHEM for
the His60-Heme coordination and PLIG for the CO-Heme coordination);
3. building the water box around the protein, a 69 Å cubic box in order
to get approximately a system with 30k atoms, as in previous Amber
simulations; this was done using the VMD Solvate extension; the water
model is TIP3P [117];
4. introducing, as substituents to water molecules, counterions in order to
have an overall neutral box; this was done using the VMD Autoionize
extension.
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step type constraints & conditions length
min1 energy minim.d non-water Hb 2000 steps
min2 energy minim.d H2O
b 5000 steps
min3 energy minim.d all atomsb 10000 steps
eq1 equilibration NVT, T=100K
50K−→300K 50000 stepsa
eq2 equilibration NPT, T=300K, p=1.0atm 100000 stepsa
mdx production dynamics NPT, T=300K, p=1.0atm n stepsa,c
Table A.1: NAMD typical pre-production and production segments division for
NP7 in solution. a The timestep for equilibration and production dynamics
amounts to a simulated time of 2 fs, see Table A.2. b Atoms hereby indicated
are those unconstrained. c Production dynamics runs span typically in the range
of hundreds of ns, and are split in shorter segments according to the computing
facility’s queuing policies. d Conjugate gradient energy minimization.
The result is a pdb-psf pair of files that, together with the files containing the
standard charmm22 parametres (with cmap corrections), are all is needed to
start the simulations.
A.1.2 Energy minimization
Common settings to all NAMD runs, independently on the particular step, in-
clude the Particle mesh Ewald method for the evaluation of long-range electro-
static interactions [88, 89], the presence of a cutoff for the evaluation of all
non-bonded (i.e. Van der Waals and coulombic) interactions and the use of the
SHAKE algorithm [81] in order to keep all bonds involving hydrogen atoms at
their equilibrium length.
The first three steps of the MD sequence are meant to make the system
more statically realistic by minimizing the system energy upon small atomic
displacements.
Since the hydrogen atoms, water molecules and counterions were auto-
matically placed with the only constraints of correct quantities and absence of
steric clashes, the energy minimization focuses initially on these sets of atoms:
non-water hydrogen atoms and then water molecules and ions. Only in a third
time, all the atoms are unconstrained and are considered by the NAMD conju-
gate gradient algorithm.
The dimensions of the periodic-boundary box are specified only in the first
energy minimization step, all subsequent steps gathering information from the
output of the previous step, as since the second equilibration step the volume
will be left free to change.
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variable value
cell shape and size cubic, l = 69Å
a
timestep 2 fs
snapshots 1 ps
boundary conditions periodic
electrostatics Particle Mesh Ewald, grid spacing 1 Å
constraints onb, harmonic
non-bonded cutoff 14 Å
non-bonded switching onc , distance 9 Å
water model TIP3P
ShakeH all H-X bonds rigid, tolerance 1× 10−5 Å
Langevin dynamics ond heavy atoms, T=300 K, damping 5ps−1
Nosé-Hoover Langevin piston one, P=1atm, period 100 fs, decay 50 fs
Table A.2: NAMD typical pre-production and production settings for NP7 in
solution. a Only specified in the min1 step (see Table A.1), subsequently taken
from last output of previous step. b Position constraints are on only during
min1 and min2 (see Table A.1). c Only active in equilibration and production
dynamics. d Only active during production dynamics. e Only active during eq2
and production dynamics.
A.1.3 Equilibration
The next two steps are meant to add dynamical realism to the system. Com-
mon variables to equilibration and production dynamics include the size of the
timestep used for the integration of Newton’s equations, 2 fs, a value that is
compatible with the use of the SHAKE algorithm.
The first equilibration phase is thermalization. Velocities are pseudoran-
domly assigned to all atoms in order to simulate a low initial temperature.
These velocities are then repeatedly modified after a certain simulation time
in order to increase the simulation temperature and allow a gradual relaxation
and adaptation of the protein structure to the new thermal motions. At the end
of this phase, the final 300 K simulation temperature is reached and some extra
time is allowed for further structural adjustments.
The second equilibration phase is pressurization. A Nosé-Hoover Langevin,
thermally-coupled piston is switched on with a target pressure of 1.0 atm at
300K, while the box dimensions are kept free to change as before.
Since the equilibration runs, an additional switching function is added to
smooth the non-bonded cutoff in order to avoid discontinuities in the potential.
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variable value
α-sphere min radius 2.8 Å
α-sphere max radius 5.5 Å
number of snapshots per traj. segment 5000
number of traj. segments ≥ 2
Table A.3: MDpocket typical settings for NP7 in solution.
variable value
resolution 0.2 Å
subsampling 3
orientations 20
cutoff energy 85
temperature 300K
nonbonded cutoff 12.0Å
probe CO: VdW radius 2.1Å / 1.7Å
probe CO: VdW epsilon -0.11 / -0.12
probe CO: charge +0.021e / -0.021e
number of snapshots per traj. segment 5000
number of traj. segments ≥ 2
Table A.4: ILS VMD plugin typical settings for NP7 in solution.
A.1.4 Production dynamics
The production dynamics runs can then start, with an additional Langevin tem-
perature control.
A.2 Auxiliary techniques
In Tables A.3, A.4 and A.5 the common settings for MDpocket (see 2.4.2), ILS
(see 2.4.3) and APBS (see 2.4.5), respectively, are summarized.
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variable value
grid points per processor 129/161
coarse grid lengths approx. 90× 80× 70Å
coarse grid lengths approx. 75× 65× 60Å
PB equation linearized
boundary conditions single Debye-Hückel
dielectric constant (protein) 20.00
dielectric constant (solvent) 78.50
dielectric ion-accessibility coefficients smola
grid points density in discont. surfaces 40.00 pt·Å−2
charge mapping cubic B-spline
solvent radius 1.40Å
spline window 0.30Å
temperature 300K
Table A.5: APBS typical settings as used in Chapter 4. a See also on
http://www.poissonboltzmann.org the APBS user guide for a complete descrip-
tion.
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Appendix B
Software
Visualization and graphics: VMD[90], grace, qtiplot, PyMOL[118];
Modeling: VMD (see above), CHARMM-GUI (http://www.charmm-gui.org)
[115], CHARMM-GUI Membrane Builder[113, 114];
MD: NAMD[76], charmm22[78];
Poisson-Boltzmann equations: APBS[107] and pdb2pqr;
sequence alignment: Clustal X[119], Treeview X;
for editing the present document: KBibTEX, pdfLATEX.
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